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ABSTRACT

The process of stationary-phase mutagenesis, also known as adaptative or stress-induced
mutagenesis, is a phenomenon where bacterial cells accumulate mutations in non-replicative
conditions. This process has mainly been studied in Escherichia coli and Bacillus subtilis;
however, the underlying mechanisms found in each of these systems differ. Here, I use B.
subtilis to study previously understudied aspects of stationary-phase mutagenesis. In this
dissertation, I describe work that has led to three major discoveries which are described below.
First in B. subtilis, Mfd is important for stationary-phase mutagenesis and its mutagenic
function at regions of the genome that are transcriptionally upregulated has been reported.
However, the mechanisms by which Mfd promotes the accumulation of mutations in stationary
phase remain elusive. Observations presented here suggest Mfd promotes mutagenesis in
stressed B. subtilis cells by synchronizing error-prone nucleotide excision repair and base
excision repair mediated by UvrA, MutY, and PolI. These processes would likely cause genetic
diversity in highly transcribed genomic regions.
Second, having established that Mfd and MutY cooperate, we next chose to further study
their involvement in the tolerance of oxidative damage. I used a genetic approach to determine
the involvement of Mfd in the tolerance of cells when exposed to different oxidants. I also
examined the involvement of these factors in stationary-phase mutagenesis. My results suggest
that Mfd protects cells from all types of oxidation tested including protein oxidation. Further, the
results suggest that oxidative stress and transcription potentiate the cooperation of Mfd and
MutY to generate stationary-phase mutations, thus limiting the mutagenic process to highly
transcribed regions.
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Finally, stressed B. subtilis cells may limit mutagenesis in space by another mechanism –
the development of a hyper-mutable sub-population. Previous work has shown that ComK, the
transcriptional regulator of the development of competence, also known as the K-state,
influences the development of mutations in stressed B. subtilis cells. By subjecting strains
differing only in ComEA, a protein essential to binding and uptake of DNA during the K-state, to
a point‐mutation reversion system, we found that stationary‐phase revertants were more likely to
be K-cells, the uptake of DNA did not influence the accumulation of mutations, and exogenous
oxidants enhanced mutagenesis in K‐cells. Therefore, the observations presented here provide
insight into how non-replicative cells limit mutagenesis to highly transcribed regions and a subpopulation. Interestingly, both mutagenic processes are potentiated by oxidative damage.
Furthermore, this research helps improve our understanding of bacterial evolution by
illuminating mutagenic mechanisms used by cells under nutritionally stressful conditions.
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CHAPTER 1
INTRODUCTION

A cornerstone of biology is the theory of evolution. In this theory, species and their traits
change over time and through the process of natural selection, which determines which traits and
species survive. These differences in species and their traits are produced by mutations in the
genomes of organisms. While mutations are an important substrate for evolution, organisms must
also reliably pass on their genetic information to their offspring – something that multiple
mutations can prevent. Consequently, cells have multiple DNA repair systems to counteract any
DNA damage and prevent mutations. Overall then, organisms must balance genome stability
with the ability to evolve as conditions change.
Even before DNA was determined to be the genetic material, scientists were aware that
certain stressors, like UV radiation and oxidative stress, induced mutations [1]. Mutation
frequency decline, or Mfd, is now known as a DNA repair protein but it originally described a
phenomenon [2]. This phenomenon was uncovered by Witkin in the 1950s and was observed
after Escherichia coli cells were exposed to UV irradiation. If cells were exposed to conditions in
which protein synthesis was halted, there was a dramatic decrease in the frequency of UVinduced prototrophic mutations which were not seen when protein synthesis continued. This
phenomenon was named Mutation frequency decline [2].
Later, through the work of several groups, the Mfd phenomenon became associated with a
specific DNA repair protein, named Mfd. When screening for a strain that was unable to perform
Mutation frequency decline, Witkin found a mutant that did not display the Mfd phenomenon
[3]. Furthermore, while the mutant grew comparably to the wild type, it was more susceptible to
UV mutagenesis. Two critical findings suggested that Mutation frequency decline was the result
1

of the lack of mutagenic enzymatic repair. The discovery of excision repair, the enzymatic
response that removes damaged lesions from the DNA, coupled with the observation that the
Mutation frequency decline phenomenon did not occur in Uvr- strains, strains deficient in the
repair of UV lesions, suggested that Mfd was the result of a specific protein [3, 4].
Research that showed DNA repair was biased to specific regions of the genome lead to
greater understanding of the role of Mfd. While investigating the repair of pyrimidine dimers in
an actively transcribed gene of hamster cells, Hanawalt and colleagues determined the repair of
these lesions was much faster than the repair rate of the same lesions when evaluated at the
genome level [5]. Furthermore, they also compared the rate of repair of the gene to surrounding
regions that were not actively transcribed. They found that the rate of repair was drastically
higher in the actively transcribed gene than in non-transcribed surrounding regions [5]. These
results suggested the involvement of a DNA repair process that prioritized the repair of bulky
lesions in actively transcribed genes over that of the general genome. Further studies in this
system showed that the transcribed strand of the actively transcribed DHFR gene was repaired
more quickly than the non-transcribed strand. Thus, these results indicated that cells
preferentially repaired lesions in actively transcribed genes and this repair was strand specific
[6]. These results, in combination with results that showed RNA polymerases (RNAP) were
irreversibly blocked at pyrimidine dimers, hinted at the requirement for a transcription-coupled
repair factor (TCRF) [7]. The TCRF would remove the stalled RNAP from the damaged bases
and recruit UvrA2B, the second protein in the nucleotide repair pathway, to the site of damage.
Strand-specific repair was first described in eukaryotic cells. It did not take long for these
observations to be applied to prokaryotic cells and mutation frequency decline [6, 8]. Through
biochemical studies, it was determined that Mfd was the TCRF in E. coli. The mutation
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frequency decline phenotype resulted from an absence of transcription-coupled repair [1, 8].
Thus, Mfd mediates this sub-pathway of the Nucleotide Excision Repair system (TC-NER).
The protein Mfd is situated at the intersection of DNA repair and transcription by targeting
paused RNAP. Since transcription is sensitive to DNA damage, a mechanism to clear stalled
RNAP is required so that mRNA elongation can proceed, otherwise unterminated mRNA
transcripts would be generated, which would likely cause a loss of cell viability. After the RNAP
is cleared from the damaged DNA, Mfd recruits the UvrA2B complex to the site of damage.
UvrB interacts with the DNA damage and recruits UvrC to the site. UvrC makes incisions
upstream and downstream of the damaged bases creating a 13-mer which is subsequently
removed by the helicase UvrD or a DNA polymerase. The resulting gap is filled in by a DNA
polymerase and sealed by ligase [9, 10].
Work by Nudler and colleagues described Mfd-independent transcription-coupled repair in
E. coli. Through RNAP pulldown and in vitro transcription assays, they uncovered a NER
pathway dependent on the UvrD helicase and independent of Mfd. In this model of NER, UvrD
pushes a stalled RNAP backwards which exposes the damaged DNA bases to UvrA2B
processing. The RNAP remains bound to the DNA and the mRNA transcript and reinitiates
transcription after the NER-mediated repair is complete [11]. This discovery leads to many
questions, including the possibility that Mfd is involved in other cellular processes beyond
transcription-coupled DNA repair.
Mfd can process RNAP pauses caused by different events that do not involve the
encountering of DNA damage. RNAP pauses caused by physical obstructions are substrates for
Mfd. An example of this is observed at the hut and gnt operons [12]. Using transposon
mutagenesis to identify factors that affect carbon-catabolite repression, Mfd was found to
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promote the expression of the hut and gnt operons during conditions of carbon catabolite
repression. The proposed mechanism for how this happens is that Mfd terminates transcription of
stalled RNAPs within these operons upon encountering the CcpA-cre DNA-protein complex.
The loss of Mfd resulted in transcriptional readthrough of the operon when CcpA disassociated
from its DNA-binding element, cre [12].
Of note, Mfd does not interact with the RNAP in protomer regions. Genes that only have cre
sites within their promoter regions, such as amyE, are unaffected by Mfd [12, 13]. This is
consistent with reports that promoter regions are not substrates for transcription-coupled repair
[14].
The interactions of Mfd and the RNAP during transcription elongation are significant and
limited to the process of transcription elongation. During elongation, RNAP may paused due to
different type of events which have two possible fates: i) transcription termination or ii) given
enough time, the resumption of transcription after the DNA-binding protein disassociates from
its site. When present, Mfd terminates transcription, and if absent, transcription elongation may
resume. These scenarios are illustrated by what happens during transcription elongation of genes
that are regulated by roadblock repressors, such as CodY. In Bacillus subtilis mfd mutant cells,
transcription levels of ybgE, bcaP, and yufN genes, members of the CodY regulon, were higher
than in wild-type cells [15].
The effects of Mfd on gene expression suggest additional roles for this factor in bacterial
physiology that extend beyond transcription-coupled DNA repair. Observations in other bacterial
species than B. subtilis support the concept that Mfd has other roles in the cell. Mfd affects
resistance to antibiotics in Campylobacter jejuni, antibiotic sensitivity in Helicobacter pylori,
and biofilm formation in Staphylococcus aureus [16-18].
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It is less clear what the role of Mfd, or its functional homologs, is in the repair of DNA bases
damaged by oxidative stress. CSB, the human equivalent of Mfd, has been reported to facilitate
the repair of damage induced by oxidative stress [19]. This process was studied in human or
murine cell lines by comparing the responses to oxidants in cells differing in CSB. Cell lines
lacking CSB were more sensitive to oxidant exposure than parental cell lines, thus implicating
CSB in the repair of oxidative DNA damage [19-22]. However, Mfd was unnecessary for E. coli
cells to recover from H2O2 exposure [23].
One noted role of Mfd is in the promotion of stationary-phase mutagenesis. Stationary-phase
mutagenesis is a phenomenon in which cells that are in non-replicative states produce mutations
with adaptive value; this phenomenon occurs in multiple species including E. coli, B. subtilis and
yeast [24-26]. Mfd is required for stationary-phase mutagenesis in B. subtilis [27, 28]. One
biological conundrum presented by the process of stationary-phase mutagenesis is the idea that
cells would likely incur a deleterious mutation before a beneficial one. However, researchers also
postulate that cells may have a mechanism to “direct” mutations to specific regions of the
genome to avoid a deleterious mutation in an essential gene [29, 30]. One way in which the cell
spares genomic regions from accumulating mutations is through the process of transcription.
During conditions of no-net growth, like amino acid starvation experienced in stationary-phase
mutagenesis assays, cells alter transcription through the stringent response by increasing the
transcription of amino acid biosynthesis genes and decreasing expression of cells involved in
growth and division. This process would limit the likelihood of a deleterious mutation occurring
in an essential gene.
Our previous work has shown that increased transcription leads to an increase in stationaryphase mutagenesis and this increase is dependent on Mfd [28, 31]. It is possible that Mfd

5

increases stationary-phase mutagenesis by coordinating error-prone NER at stalled RNAP sites.
It is also possible that Mfd works with additional yet-to-be described error-prone DNA repair
pathways to produce mutations in conditions of no-net growth.
Stressed B. subtilis cells may use multiple mechanisms to limit mutagenesis and avoid
genetic load. It has been hypothesized that cells may limit mutagenesis to a subset of the
population to decrease the detriments of hyper-mutation [25]. This hypermutable sub-population
would have an increased mutation rate while the rest of the population would be protected from
this risky strategy. Therefore, only a small fraction of cells would activate a hyper-mutable
mechanism, while the remaining cells would not risk the integrity of their genetic information.
The work presented here seeks to answer two aspects in the field of stationary-phase
mutagenesis. First, I examined the genetic interactions between Mfd and DNA repair factors in
the formation of mutations in stationary-phase cells. Also, I examine how the subpopulation of
cells that enter the K-state promotes mutagenesis. Additionally, I examined the enhancing nature
of oxidative damage on these mutagenic mechanisms. Understanding how stationary-phase
mutagenesis occurs through the actions of Mfd is critical to our understanding of the
evolutionary process and its implications in human health. These include the development of
neoplasia as well as antibiotic resistance and host evasion of bacterial pathogens. Therefore, a
better understanding of stationary-phase mutagenesis and Mfd has the potential for developing
therapeutic targets to ease the increase in antibiotic resistance and developmental diseases in
humans.
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Abstract
In replication-limited cells of Bacillus subtilis, Mfd is mutagenic at highly transcribed
regions, even in the absence of bulky DNA lesions. However, the mechanism leading to
increased mutagenesis through Mfd remains currently unknown. Here, we report that Mfd may
promote mutagenesis in nutritionally stressed B. subtilis cells by coordinating error-prone repair
events mediated by UvrA, MutY and PolI. Using a point-mutated gene conferring leucine
auxotrophy as a genetic marker, it was found that the absence of UvrA reduced the Leu+
revertants and that a second mutation in mfd reduced mutagenesis further. Moreover, the mfd and
polA mutants presented low but similar reversion frequencies compared to the parental strain.
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These results suggest that Mfd promotes mutagenic events that required the participation of NER
pathway and PolI. Remarkably, this Mfd-dependent mutagenic pathway was found to be epistatic
onto MutY; however, whereas the MutY-dependent Leu+ reversions required Mfd, a direct
interaction between these proteins was not apparent. In summary, our results support the concept
that Mfd promotes mutagenesis in starved B. subtilis cells by coordinating both known and
previously unknown Mfd-associated repair pathways. These mutagenic processes bias the
production of genetic diversity towards highly transcribed regions in the genome.

Contribution Statement
I am a co-first author of this publication.

Introduction
Stationary-phase mutagenesis (SPM), also referred to as stress-induced mutagenesis, is
the collection of cellular processes that produces genetic alterations in non-growing cells. These
processes are well conserved, have been implicated in genome instability, and are viewed as
mechanisms that produce genetic diversity and speed evolution in times of stress [1–4]. It is
possible that during conditions of stress or in nutrient-limited cells mechanisms that bias
mutagenic events towards highly transcribed genes are activated, thus increasing the adaptive
potential of mutations [5–7].
In 1966, Witkin and coworkers described for the first time a genetic factor that prevented
the formation of mutations induced by exposure to ultraviolet (UV) light. Escherichia coli cells
proficient in this factor expressed a mutation frequency decline (mfd) phenotype [8]. Subsequent
studies showed that Mfd is a key component of transcription-coupled repair (TCR), which directs
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the nucleotide excision repair (NER) system to UV-lesions occupying the template strand in
transcribed regions [9]. In E. coli, genetics and biochemical evidence indicates that Mfd mediates
high-fidelity repair of DNA lesions or removal of obstacles that block the progress of the RNA
polymerase (RNAP) during active transcription [10–14]. At stalled or blocked RNAP-DNA
complexes, Mfd first binds RNAP, then dissociates the transcription elongation complex and
finally recruits proteins of the NER system. Recruitment of UvrAB2 complex initiates incision of
the template strand and enlists UvrC to the site of damage. The UvrBC complex generates
incisions flanking the transcription-stalling DNA lesion. UvrD, a helicase, removes the ~13 b
DNA fragment containing the lesion and generates a single-stranded gap to be filled by DNA
PolI and sealed by ligase A [15]. Currently, structural and single-molecule resolution
experiments are investigating how Mfd interacts with RNAP, whether it translocates to the
lesion, and how it recruits Uvr proteins [13,14].
It has been also proposed that Mfd may recruit DNA repair proteins, other than the
UvrAB2 complex from the NER system, to the template strand [14]. In non-replicating E. coli
cells, Mfd prevented transcriptional bypass of DNA templates containing lesions of oxidative
nature or DNA-repair intermediates generated by proteins that eliminate ROS-promoted DNA
damage (known to be part of the base excision repair system (BER)) [16,17], which raises the
possibility that Mfd may interact with components of the BER system, specifically with DNA
glycosylases or apurinic/apyrimidinic (AP) — endonucleases that recognize these types of
lesions [18,19].
In the context of mutagenesis, previous experiments showed that Mfd deficiency had no
effect on the reversion frequency of a tyr allele in E. coli cells starved for tyrosine [20]. It has
been shown that Mfd promotes origin-independent replication restarts and formation of
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recombination intermediates, and that these events may generate point mutations or
amplifications [7]. In Bacillus subtilis, a recent report showed that Mfd, the NER system and
PolY1, an error-prone DNA polymerase, are all part of a mutagenic pathway that prevents
conflicts between transcription and replication [21].
In starved or replication-limited Bacillus subtilis cells, Mfd is mutagenic. However, the
molecular basis of such a process remains unknown [22]. It is well established that stationaryphase B. subtilis cells halt DNA replication [23–25]. Then, one would expect that the mutagenic
contribution of conflicts between transcription and replication is severely reduced or abrogated.
In addition, while Mfd is required for stationary-phase mutagenesis [22], recombination
functions are not [26]. This is in stark contrast to how stress-induced mutagenesis occurs in E.
coli, in which recombination-repair functions are necessary to produce mutations (reviewed in
[2,27]).
An idea considered in the present study is that Mfd generates stationary-phase mutations
through its TCR activities and error-prone DNA synthesis. Recent reports have associated UvrD
with a TCR process; in this mechanism, the helicase activity of UvrD operates to backtrack
stalled RNAP at DNA lesions, this event then uncovers DNA damage to be accessed by repair
systems [28]. Moreover, NusA, proposed to take part in UvrD-mediated TCR [28], and errorprone DNA synthesis, have been associated with stress-induced mutagenesis in E. coli [29,30].
Another possibility addressed here was the association of Mfd with BER proteins,
specifically the DNA glycosylase MutY, which has been implicated in the generation of
stationary-phase mutations in B. subtilis [31]. In this regard, it has been reported that
accumulation of base mismatches saturates the mismatch repair (MMR) capacity and promotes
stationary-phase mutagenesis through a mechanism that involves processing of A-C or A-G
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mismatches by MutY [31]. Here we present evidence indicating that Mfd combines with UvrA,
MutY and PolI in the formation of mutations at leuC427 mutant allele and therefore expanding
the transcription-mediated mutagenic functions of Mfd beyond NER in replication-limited cells.

Materials and Methods
Bacterial Strains and Growth Conditions
Strain YB955 is a prophage-“cured” B. subtilis strain 168 containing point mutations in
three genes, metB5 (ochre), hisC952 (amber), and leuC427 (missense) [26]. B. subtilis strains
employed in this study (Table 2.1) were routinely isolated on tryptic blood agar base (TBAB)
(Acumedia Manufacturers, Inc., Lansing, MI, USA), and liquid cultures were grown in Penassay
broth (PAB) (antibiotic medium 3, Difco Laboratories, Sparks, MD, USA) supplemented with
1X Ho-Le trace elements [32]. E. coli cultures were grown in Luria-Bertani (LB) medium. When
required, tetracycline (Tet; 10 μg∙mL-1), spectinomycin (Sp; 100 μg∙mL-1), ampicillin (Amp; 100
μg∙mL-1), chloramphenicol (Cm; 5 μg∙mL-1), erythromycin (Em; 1 μg∙mL-1) or isopropyl-β-Dthiogalactopyranoside (IPTG; 1 mM) was added to media.

Construction of Mutant Strains
B. subtilis strains carrying single, double and triple mutations were generated as indicated
in Table 2.1, employing standard techniques. The pBT and pTRG vectors containing mutY
(PERM1084) and mfd (PERM1072) genes were generated as mentioned below. The mutY and
mfd ORFs were first amplified by PCR using chromosomal DNA purified from B. subtilis
YB955 with the following set of oligonucleotide primers: for mutY, 5’CGGGATCCATGAACGTACTTGAAGAC-3’ (forward) and 5’-
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CGCTCGAGCGGAGCAGCCGAGATGGC-3’ (reverse); for mfd, 5’CGGGATCCATGGACAACATTCAAACC-3’ (forward) and 5’CGCTCGAGCGTTGATGAAATGGTTTG-3’ (reverse). Primers were designed to insert
BamHI/XhoI sites in both cases (sequences underlined). Amplifications were performed with
Vent DNA polymerase (New England BioLabs, Beverly, MA, USA). PCR products purified
from a low-melting-point agarose gel were ligated into PCR-BluntII-TOPO (Invitrogen,
Carlsbad, CA, USA). The resulting constructs were treated with NotI/XhoI and BamHI/XhoI to
release mutY and mfd ORFs. The purified fragments were ligated into pBT and pTRG to generate
the constructs PERM1084 and PERM1072. The correct orientation of the inserted genes was
verified by restriction analysis.

Stationary-Phase Mutagenesis Assays
The stationary-phase mutagenesis assay was conducted as described by Sung et al. [26].
Cultures were grown in flasks containing antibiotic PAB and Ho-Le trace elements [32] with
aeration (250 rpm) at 37 °C until 90 min after the cessation of exponential growth (designated
T90 (90 min after the time point in the culture when the slopes of the logarithmic and stationary
phases of growth intercepted). Growth was monitored with a spectrophotometer measuring the
optical density at 600 nm (OD600). Cells were harvested by centrifugation (10,000 x g, 10 min),
resuspended in 10 mL of Spizizen minimal salts (SMS) [36] and plated in quintuplicate onto
solid Spizizen minimal medium (SMM; 1_ Spizizen salts supplemented with 0.5% glucose, 50
μg∙mL-1 of each methionine, histidine, isoleucine and glutamic acid, and 200 ng∙mL-1 of leucine).
To induce mutY and mfd expression, the selection medium was supplement with 1 mM IPTG
mL-1. The plates were incubated for 9 days. Each day plates were scored for the appearance of
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Leu+ colonies. The initial titer of B. subtilis cells was determined by serially diluting the
resuspended culture and spread plating on SMM containing 50 mg/mL of histidine, methionine,
leucine, isoleucine, and glutamic acid. Colonies were counted after 48 h of incubation. The initial
titers were used to normalize the cumulative number of revertants per day to the number of CFU
plated. Assays were repeated at least three times for each tested strain.

Analysis of Mutation Rates
The growth-dependent reversion rates for Leu were measured by fluctuation tests with
the Lea-Coulson formula, r/m-ln(m) = 1.24 [37]. Three parallel cultures were used to determine
the total number of CFU plated on each plate (Nt) by titration. The mutation rates were
calculated as previously described with the formula m/2Nt [26,38,39].

Beta-Galactosidase Assays
B. subtilis strains PERM1123, containing a transcriptional mfd-lacZ fusion (Table 2.1),
were propagated in liquid PAB medium. Aliquots of 1.5 mL were collected from cultures at
exponential growth phase and stationary phase and processed for determination of βgalactosidase activity as previously described [40].

Quantitative Real-Time PCR
Total RNA was isolated from exponentially growing (0.5 of OD600 nm) and stationaryphase (T90) B. subtilis YB955 cells grown in A3 medium was isolated by using TRIzol reagent
(TRI reagent, Molecular Center, Inc., Cincinnati, OH, USA). The mRNA isolated was reverse
transcribed and amplified for real-time PCR using a One-Step SYBR Green qRT-PCR (Quanta,
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Biosciences, Beverly, MA, USA). Master mixes of 25 μL of One-Step SYBR Green qRT-PCR
containing 50 ng of RNA and 300 nM final concentration of mfd primers (forward, 5’AGAAGAATGCTGCCGCCTGTT-3’ and reverse 5’-CCGCTCATACCCTACCTCTACCAG3’, 117-bp amplicon) or veg primers (forward, 5’-TGGCGAAGACGTTGTCCGATA-3’ and
reverse 5’-CGGCCGCCGTTTGCTTTTAAC-3’, 82-bp amplicon). Three replicates from each
culture condition were assayed and normalized to the expression of the internal control gene veg
[41,42]. One reaction was assessed with no reverse transcriptase and no-template as controls.
Quantitative real-time PCR was run on a Bio-Rad iCycler iQ Real-Time PCR Detection System
(Bio-Rad, Hercules, CA, USA), using the manufacturer’s suggested protocol and an annealing
temperature of 60 °C. Results were calculated by the 2-ΔΔCT (where CT is threshold cycle)
method for relative fold expression [43].

Results
Transcription-Coupled Nucleotide Excision Repair Produces Stationary-Phase Mutations at
leuC427 gene
We constructed mutants lacking Mfd and UvrA and assayed the strains’ ability to
produce stationary-phase leucine revertants (Leu+). Results revealed that whereas disruption of
mfd completely abolished the production of Leu+ revertants, the absence of UvrA only promoted
a partial decrease in this mutagenic event (Fig. 2.1). Of note, the reversion frequency values to
leuC were similar in the mfd and mfd/uvrA double mutants (Fig. 2.1), suggesting that Mfd was
epistatic onto UvrA to produce stationary-phase Leu+ revertants. Therefore, transcriptioncoupled nucleotide excision repair is only partially involved in SPM and pointed to the role of
additional factors interacting with Mfd to generate mutations in conditions of nutritional stress.
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Because PolI executes the DNA synthesis step during transcription-coupled repair, we
inquired whether this polymerase is involved in Mfd-mediated Leu+ SPM. Strains lacking Mfd or
PolI were measured for their ability to accumulate Leu+ revertants. Results showed that in
comparison to the parental strain YB955, the polA mutant presented very low but similar levels
of Leu+ revertants as those produced by the Mfd-deficient strain (Fig. 2.2). These results suggest
that Mfd and PolI are part of a pathway additional to, and different from, TCR that generates
mutations at leuC427 in stationary-phase cells. Of note, the levels of SPM-dependent Leu+
reversions shown in Figures 2.1 and 2.2 cannot be attributed to viability levels of the strains (Fig.
2.3).

An Mfd Mutagenic Pathway Operates through MutY Activity Producing Leu+ SPM
As noted above, the NER pathway (UvrA) partially contributed in generating stationaryphase Leu+ reversions suggesting that Mfd-mediated SPM proceeds through both transcriptioncoupled nucleotide excision repair and an alternate, yet-to-be known mechanism(s). Previous
results revealed that the mutagenic changes occurring at leuC427 in the strain YB955 during
stationary phase are not generated via oxidative damage to DNA bases [31,44]. However, a
subsequent set of experiments showed that such reversion events depended on the activity of the
MutY DNA glycosylase, a component of the oxidized guanine (GO) repair system of B. subtilis
[31,44]. Since Mfd is also required to generate adaptive Leu+ revertants [22], we investigated
whether Mfd works in coordination with MutY to generate Leu+ revertants, or if these proteins
contribute through independent mechanisms to these mutagenic events.
To this end, we constructed a series of strains deficient in both mutY and mfd, as well as
an expression system for either mfd or mutY under the transcriptional control of an IPTG-
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inducible promoter. As shown in Figure 2.4, with respect to the YB955 (parental strain), the
mutY/mfd double strain completely abrogated the production of Leu+ revertants in starved B.
subtilis cells. Notably, expression of Mfd from the IPTG-inducible Pspac promoter significantly
increased the reversion levels of the leuC gene. In marked contrast, expression of MutY in the
same background did not result in increased Leu+ reversion levels (Fig. 2.4). The IPTG-inducible
mutY construct used in these experiments restored the Leu+ mutagenesis in mutY cells (Fig. 2.4
and [31]), therefore, we can rule out possible defects in the inducible MutY construct. The lack
of response when MutY was overexpressed suggested that production of leuC reversion through
MutY is dependent on a functional Mfd. In addition, the response observed when Mfd was
overexpressed supports the idea that Mfd employs alternative pathways to promote stationaryphase mutations independently of MutY.
Two-hybrid assays were conducted to determine whether MutY directly interacted with
Mfd to produce Leu+ mutations. In this assay system, PERM1072 was constructed as a target
(pTRG-mfd) and PERM1084 as bait (pBT-mutY) (Table 2.1). The positive control demonstrated
an interaction that manifested by abundant growth on screening medium (SM) after transforming
the reporter cells with the pTRG-Gal11P and the pBT-LGF2 plasmids. To rule out self-activation
induced by the transformation of recombinant pBT or pTRG in the BacterioMatch reporter
strain, transformations were performed using either recombinant pBT-mutY and the empty pTRG
or pBT vector and recombinant pTRG-mfd. No significant growth of colonies on screening plates
was observed in either case (Fig. 2.5). All positive and negative controls provided expected
results (Fig. 2.5). Interestingly, when the interaction pair was switched (pTRG-mfd and pBTmutY), no growth of the E. coli indicator strain was detected on the screening medium (Fig. 2.5)
suggesting a lack of direct interaction between MutY and Mfd proteins. Of note, the absence of
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growth on screening medium cannot be attributed to deficient reporter strain transformation. In
all cases, abundant growth of colonies was observed on non-screening medium (NSM) (Fig. 2.5).

MutY and UvrA Act in Independent Stationary-Phase Mutagenic Pathways that Require Mfd
Because Mfd was central to mechanisms that result in Leu+ mutagenesis through UvrA
and MutY, we tested whether these proteins are in the same mutagenic route. To this end, we
estimated mutation rates in backgrounds lacking uvrA and/or mutY. The results showed that
deletion of mutY significantly reduced the levels of Leu+ revertants produced by the uvrA mutant;
in fact, as shown in Figure 2.4, the reversion values obtained in the UvrA MutY-deficient strain
were similar to those presented by the single mutY mutant. Interestingly, disruption of Mfd in the
uvrA mutY genetic background almost completely abolished the production of Leu+ revertants
(Fig. 2.6). Altogether, these results provide genetic evidence that UvrA and MutY act in
independent mutagenic pathways that requires the participation of Mfd.

Mfd is Highly Expressed during Stationary Phase of B. subtilis
The mutagenic events mediated by Mfd have mainly been associated to the stationary
phase of growth [22,45]; therefore, we first analyzed the temporal pattern of expression of a
transcriptional mfd-lacZ fusion inserted into the mfd locus of strain YB955. To this end, the
strain PERM1123 (mfd-lacZ) was propagated in Penassay broth (PAB) medium and assayed for
mfd-driven expression of β-galactosidase during both exponential and stationary phases of
growth. Expression of the reporter gene took place in all stages of growth; however, such levels
were significantly higher during the stationary phase of growth (Fig. 2.7 A). Expression of mfd
was further analyzed by real-time polymerase chain reaction (qPCR) assays. The results showed
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that the amount of mfd mRNA detected in stationary phase (T90, 90 min after the time point in
the culture when the slopes of the logarithmic and stationary phases of growth intercepted) was
four times higher than that observed in exponentially growing cells (Fig. 2.7 B).

Discussion
Mfd has been extensively studied in actively growing cells in the context of high-fidelity
repair and as a factor influencing replisome progress through obstacles [21] and originindependent replisome assembly [7]. The results presented here provide insights into yet another
Mfd-dependent cellular functions: those that generate mutations in non-replicating and
nutritionally stressed cells (SPM). First, our observations suggest that Mfd-dependent mutagenic
functions proceed partly through its interactions with proteins of the NER system, since
inactivation of uvrA partly decreases mutagenesis. A second set of results has also revealed that
Mfd is flexible to indirectly coordinate base excision repair events that culminate in SPM.
Based on the results where Mfd was epistatic onto UvrA to produce stationary-phase
Leu+ revertants (Fig. 6.2), we postulate that an error-prone mechanism involving Mfd and
components of the NER system can be activated by DNA lesions (e.g., pyrimidine dimers or
abasic sites) in the transcribed strand that stall the transcriptional machinery. In this mechanism,
Mfd would be necessary to disassemble the stalled RNA polymerase and to recruit the UvrABC
system that excises and eliminates the lesions. In support of this mechanism, a recent report
showed that Mfd promotes NER-dependent mutagenic events in the lagging-DNA strand in
actively growing B. subtilis cells [21]. Within this pathway it is also possible that a transcribing
RNAP may pause at a protein–DNA complex that would recruit the NER system to initiate a
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gratuitous repair reaction that introduces a mutation. Indeed, a previous report in E. coli has
revealed that even undamaged DNA can be used as a substrate by the NER machinery [46].
Our results also showed that Leu+ mutagenesis promoted by Mfd required the activity of
PolI (Fig. 2.2). Consistent with the notion that PolI may carry out error-prone DNA synthesis, a
previous report showed that, unlike in E. coli, B. subtilis PolI lacks proofreading activity [33,47].
Moreover, previous reports have also indicated that PolI promote mutagenic events even in the
absence of exogenous DNA damage [33,48].
The contribution of the NER pathway to Mfd-mediated mutagenesis was partial. The
absence of UvrA decreased SPM but not to the levels observed in the single mfd mutant (Fig.
2.1). This pointed to the possibility that Mfd could interact with other factors in the formation of
stationary-phase mutations. A recent study showed that processing of A-G/C mismatches that
accumulate in starved B. subtilis by the DNA glycosylase MutY is involved in generating SPMassociated Leu+ reversions [31]. Results obtained in this work strongly suggest that the MutYdependent mutagenic event leading to generation of Leu+ revertants requires the participation of
Mfd (Fig. 2.4). Even more interesting were the results from the epistatic analysis performed with
Mfd, UvrA and MutY (Fig. 2.6) suggesting the participation of these proteins in independent
pathways that require Mfd to promote mutagenic events in nutritionally stressed B. subtilis cells.
Based on current and previous results, we propose a model for production of reversions
in the leuC427 allele resulting in a Leu+ prototrophic phenotype in non-growing/non-replicating
B. subtilis cells. A-G/C mismatches (recognized by MutY) generated in non-growing cells [31]
are processed by MutY to eliminate adenine from the mismatch and generate an AP site.
However, due to the high cytotoxicity of AP sites [18], it has been shown that MutY remains
tightly bound to this lesion to protect the DNA from further damage until yet-to-be determined
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downstream components promote the release of MutY to allow repair of the AP site by BER
components [49,50]. Thus, we speculate that the MutY-AP site complex stalls RNA polymerase
during transcription of leuC427 and activates the Mfd-dependent event to generate the A to G
reversion in this allele [26]. In this context, the function of Mfd is then required to dissociate the
transcription elongation complex through its interaction with the RNA polymerase followed by
recruitment of excision and DNA repair synthesis activities. This model is in agreement with the
results that ruled out a direct interaction between Mfd and MutY (Fig. 2.5) and explains why the
production of Leu+ revertants by MutY requires the participation of Mfd (Fig. 2.4). Since NER is
partially involved in leuC mutagenesis (Fig. 2.1), a BER-dependent mechanism mediated by the
AP endonucleases Nfo, ExoA and/or Nth and error-prone synthesis by PolI could also complete
the error-prone repair event. In support of this notion, previous reports have shown that the
mismatch repair machinery becomes suppressed during stationary phase which would increase
A-G/C mismatches [38]. It was also recently found that AP sites that accumulate in stationaryphase cells are processed by Nfo, ExoA and/or Nth in an error-prone manner by the DNA
polymerase PolX [19].
No significant differences in the production of growth-associated Leu+ revertants were
observed between the parental strain YB955 and mutants of the Mfd-UvrA-PolA-dependent
pathway described in this work (Table 2.2). These results support the concept that the Mfd-NER
mediated mutagenic events are specific to conditions in which DNA replication and cell growth
are limiting. A trademark of stationary-phase B. subtilis cells is the development of differentiated
sub-populations (e.g., the cells that develop competence are different from those that give rise to
endospores). These subpopulations form under conditions in which DNA replication and cell
division are halted [23–25] and require the activation of specific genetic programs (K and Spo
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transcription factors). A recent report on the role of Mfd in the population of cells that develop
into spores demonstrated that this factor was important for efficient production of spores but
prevented the formation of mutations [34]. The latter is the opposite of what occurs in the rest of
stationary-phase cells. These observations are significant because they provide support for the
concept that a stressed B. subtilis culture differentiates cells to either increase genetic diversity or
to protect genome integrity and develop dormancy. In regard to Mfd, these
observations substantiate the idea that this factor may be both a repair and transcription
modulation actor, and therefore may have different roles in vivo.
In a much broader perspective, transcription-mediated mutagenesis allows the study of
genetic processes in cells under mitotic arrest. Further, the factors governing transcriptionassociated mutagenesis have been associated with antibiotic resistance in bacterial pathogens, the
development of neoplasia as well as other human diseases [51,52]. In addition, these factors have
been linked to the formation of transient phenotypes and the development of certain cancers [52–
54]. In bacteria, the factors studied here have recently been implicated in the acquisition of
fluoroquinolone-resistant mutations or the ability to withstand higher inhibitory doses of several
antibiotics [51,55]. Therefore, further study of these factors has a great potential for developing
therapeutic targets to mitigate the increase in antibiotic resistance, as well as treat developmental
diseases in humans. From an evolutionary standpoint, mechanisms such as transcriptionmediated mutagenesis may help to explain how a population of pathogenic cells produces
genetic diversity during chronic infections [56].

26

Conclusions
We propose that Mfd promotes mutagenesis in starved B. subtilis cells by coordinating
both known (NER) and previously unknown (MutY and PolI) associated repair pathways and
support the concept that stressed cells bias the production of genetic diversity towards highly
transcribed regions in the genome.
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Figures & Tables

Table 2.1. Strains and plasmids used in this study.
Strain Name

Relevant genotype

Reference or Source

YB955

hisC952 metB5 leuC427 xin-1 SpβSENS

26

YB9801

YB955 mfd::tet, Tetr

22

YB9900

YB955 uvrA::em, Emr

JJS164

TF8a ΔpolA::sp, Spr

AMP100

YB955 ΔpolA::sp, Spr

AMP101

YB9801 ΔpolA::sp, Spr

BSU35160

168 uvrA::erm, Emr

BSU351 → YB955

a

33
a
a

JJS164 → YB955
JJS164 → YB9801

Bacillus Genetic Stock Center
(BKE Knock-out collection)

YB955 uvrA::em mfd::tet, Emr Tetr

PERM598

168 mutY::sp, Spr

31

PERM687

YB955 uvrA::sp, Spr

Peter Setlow

PERM704

YB955 mutY::sp, Spr

31

PERM899

YB955 mutY::sp amyE::Phs-mutY, Cmr

31

PERM818

YB955 mfd::tet mutY::sp, Tetr Spr

PERM995

YB955 mfd::tet mutY::sp amyE::Phs-mfd, Cmr

PERM1029

YB955 mutY::em, Emr

PERM1041

YB955 mfd::tet mutY::em, Tetr Emr
YB955 mfd::tet mutY::em amyE::Phs-mfd, Tetr

PERM1042

r

r

a

YB9900 → YB9801

HAM300

a
b

pPERM852 → PERM818
b
b

b

PERM598 → YB9801

pPERM979 → YB955

pPERM979 → YB9801

pPERM1041 → PERM1041

Em Sp

YB955 mfd::tet mutY::em amyE::Phs, Tetr Emr
PERM1046

b

pdrE amyE → PERM1041

a

PERM1029 → PERM687

r

Sp
PERM1352

YB955 mutY::em uvrA::sp, Emr Spr

PERM1353

YB955 mfd::tet mutY::em uvrA::150, Tetr Emrr

PERM1123

168 pMUTIN4::mfd-lacZ, Emr

28

a

PERM1029 → PERM1352
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Plasmids

Description

Reference or Source

pHyperspank

Integrative vector, Spr

David Rudner

pDR244

cre, temperature-sensitive replication Ampr Spr

Bacillus Genetic Stock Center
(BKE Knock-out collection)

pHyperspank-mutY Integrative vector with mutY
pPERM852
pPERM979

control by IPTG, Ampr Cmr
pMUTIN4::mutY, Ampr Emr

31
This study; 35

pHyperspank-mfd Integrative vector with mfd
pPERM1043

under the control of IPTG, Ampr Spr

This study

pPERM1084

pBT-mutY, Cmr

This study

pPERM1072

pTRG-mfd, Tetr

This study

a

Chromosomal DNA from the strain to left of the arrow was used to transform the strain to the

right of the arrow; b DNA of the plasmid to the left of the arrow was used to transform the strain
to the right of the arrow; Amp, ampicillin; Cm, chloramphenicol; Em, erythromycin; Neo,
neomycin; Sp, spectinomycin; Tet, tetracycline; r Denotes phenotype of antibiotic resistance.
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Figure 2.1. Mfd works with UvrA to produce stationary phase mutations. Stationary-phase
induced reversions to leu mutant allele of the YB955 (parental strain) (white circles), PERM687
(uvrA) (black squares), YB9801 (mfd) (black circles) and HAM300 (uvrA mfd) (white triangles)
B. subtilis strains were determined as described in Material and Methods. Data represent the
average of three separate tests ± standard error of the mean (SEM).
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Figure 2.2. The stationary-phase mutagenesis requires PolI. The accumulation of Leu+ revertants
of the YB955 (parental strain) (white circle), AMP100 (polA) (black squares), YB9801 (mfd)
(black circles), and AMP101 (polA mfd) (white triangles) B. subtilis strains were obtained as
described in Materials and Methods. Data represent the average of three separate tests ± standard
error of the mean (SEM).
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Figure 2.3. Survival of strains used in stationary phase assays subjected to leucine starvation.
Three plugs of bacteria containing agar were taken from zones of the selection plates where no
growth of revertant colonies was observed. Titers were determined on media containing all
essential amino acids every other day for testing of viability of non-revertant background cells.
Results presented are average values ± SD from three independent experiments.
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Figure 2.4. MutY and Mfd act in the same mutagenic pathway. Stationary-phase Leu+ reversions
in the YB955 (parental strain), PERM818 (mfd mutY), PERM1046 (mfd mutY amyE::Phs),
PERM995 (mfd mutY amyE::Phs-mutY) PERM1042 (mfd mutY amyE::Phs-mfd), PERM704
(mutY) and PERM899 (mutY amyE::Phs-mutY). B. subtilis strains were determined as described
in Material and Methods. Data represent the average of three separate tests ± standard error of
the mean (SEM).
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Figure 2.5. Bacterial two-hybrid screening to detect physical interactions between MutY and
Mfd. Top panel, transformants plated on Non-selected Screening medium (NSM) lacking 3amino-1,2,4-triazole (3-AT). Bottom panel, transformants selected on Screening Medium (SM)
plates containing 5 mM 3-AT. Positive Control, transformants containing pBT-LGF2 and pTRGGall lp plasmids. Negative Control I, transformants containing pBT-mutY (PERM1084) and
pTRG plasmids and Negative Control II, transformants containing pBT and pTRG-mfd
(PERM1072) plasmids. Interaction assay, transformants containing pBT-mutY (PERM1084) and
pTRG-mfd (PERM1072) plasmids. See Material and Methods section for more details.
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Figure 2.6. MutY- and NER-dependent SPM pathways operate through Mfd. Frequencies of
stationary-phase reversions for leu mutant allele of the B. subtilis strains YB955 (parental strain)
(white circles), PERM687 (uvrA) (black squares), PERM704 (mutY) (black circles), PERM1352
(uvrA mutY) (white triangles) and PERM1353 (uvrA mutY mfd) (white squares) were obtained as
described in Materials and Methods. Data represent the average of three separate tests ± standard
error of the mean (SEM).
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Figure 2.7. Analysis of Mfd expression during the growth cycle of B. subtilis. (A) Levels of βgalactosidase of a mfd-lacZ transcriptional fusion were measured during the exponential and
stationary phase of growth. B. subtilis strain PERM1123 was grown in liquid antibiotic (A3)
medium. Cell samples were collected at the indicated times and treated with lysozyme, and the
extracts were assayed for β-galactosidase as described in Materials and Methods. Data shown are
average values from triplicate independent experiments SD for β-galactosidase specific activity
(black circles) and for A600nm values (white circles). (B) Relative fold change of mfd mRNA
levels in YB955 strain determined by qRT-PCR assays. Levels of mRNA from cultures in
exponential growth were compared to stationary phase mRNA levels. The veg gene was used to
standardize expression. The data shown are average values for triplicate independent
experiments ± standard deviations (SD).
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Table 2.2. The spontaneous Leu+ reversion rates for YB955 and derivatives.
Strain

Mutation Rate

*Confidence Value

YB955

2.35 E-08

±0.81

mfd (YB9801)

1.92 E-08

±1.23

polI (AMP100)

2.14 E-08

±1.33

uvrA (PERM687)

2.00 E-08

±0.12

mutY (PERM704)

0.34 E-08

±0.13

uvrA mutY (PERM1352)

0.19 E-08

±0.10

mfd uvrA (HAM300)

1.70 E-08

±1.12

mfd mutY (PERM1041)

0.18 E-08

±0.25

mfd mutY amyE::Phs (PERM1046)

0.15 E-08

±0.42

mfd mutY amyE::Phs-mutY (PERM995)

0.27 E-08

±0.33

mfd mutY amyE::Phs-mfd (PERM1042)

0.25 E-08

±0.04

*Error is representative of the 95% confidence value.
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CHAPTER 3
MFD PROTECTS AGAINST OXIDATIVE STRESS IN BACILLUS SUBTILIS
INDEPENDENTLY OF ITS CANONCIAL FUNCTION IN DNA REPAIR
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Forward
The previous chapter describes two Mfd-dependent mechanisms that promote the formation
of mutations in stationary phase Bacillus subtilis cells. In the first of these mechanisms, Mfd
coordinates mutagenesis through its previously described role in Nucleotide Excision Repair.
However, this type of repair can become error prone in stressed cells due to the upregulation of
error-prone polymerase. The second Mfd-dependent mutagenic mechanism was through a novel
interaction with the DNA glycosylase, MutY. Though a physical interaction between Mfd and
MutY was not observed, genetic assays suggest these proteins work in the same pathway to
generate mutations in stressed B. subtilis cells.

44

The following chapter examines the relationship between Mfd and MutY further. Because MutY
functions to counter oxidative damage, the influence of Mfd on oxidative damage was
investigated. Genetic studies were completed to determine which of the known Mfd pathways
are involved in Mfd-dependent protection to oxidative stress. Furthermore, the interplay of Mfd,
MutY, and oxidative damage on stationary-phase mutagenesis was studied. Finally, Mfd was
determined to protect against protein oxidation independently of its known roles in DNA repair.
Thus, these chapters illustrate the involvement of Mfd in the mutagenic processes of stressed
Bacillus subtilis cells.

Abstract
Background: Previous reports showed that mutagenesis in nutrient-limiting conditions is
dependent on Mfd in Bacillus subtilis. Mfd initiates one type of transcription-coupled repair
(TCR); this type of repair is known to target bulky lesions, like those associated with UV
exposure. Interestingly, the roles of Mfd in repair of oxidative-promoted DNA damage and
regulation of transcription differ. Here, we used a genetic approach to test whether Mfd protected
B. subtilis from exposure to two different oxidants.
Results: Wild-type cells survived tert-butyl hydroperoxide (t-BHP) exposure significantly
better than Mfd-deficient cells. This protective effect was independent of UvrA, a component of
the canonical TCR/nucleotide excision repair (NER) pathway. Further, our results suggest that
Mfd and MutY, a DNA glycosylase that processes 8-oxoG DNA mismatches, work together to
protect cells from lesions generated by oxidative damage. We also tested the role of Mfd in
mutagenesis in starved cells exposed to t-BHP. In conditions of oxidative stress, Mfd and MutY
may work together in the formation of mutations. Unexpectedly, Mfd increased survival when
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cells were exposed to the protein oxidant diamide. Under this type of oxidative stress, cell
survival was not affected by MutY or UvrA.
Conclusions: These results are significant because they show that Mfd mediates errorprone repair of DNA and protects cells against oxidation of proteins by affecting gene
expression; Mfd deficiency resulted in increased gene expression of the OhrR repressor which
controls the cellular response to organic peroxide exposure. These observations point to Mfd
functioning beyond a DNA repair factor in cells experiencing oxidative stress.

Contribution Statement
I am a co-first author of this publication.

Background
Reactive oxygen species (ROS) are a collection of chemical species that contain one or
more unpaired electrons such as superoxide, hydroxyl radical, and hydrogen peroxide [1, 2].
Oxygen radicals and non-radical oxidizing agents that can be directly modified into radicals are
members of this class. Because of their reactivity, these species damage all cellular components,
including nucleic acids and proteins. There are many sources of ROS in the environment [3].
However, one endogenous source is from respiration, which makes ROS inescapable sources of
damage that inflict cytotoxic and genotoxic effects on cells [4, 5].
In B. subtilis, a bacterial model for cell growth and differentiation, the cytotoxic effects
of oxidative stress are countered by regulons under the control of several transcription factors
(e.g., PerR, OhrR, Spx, YodB, SigB, and MgsR); some of them are activated by sensing the
redox state of the cell [6]. These regulons have been elucidated by experiments examining how
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cells respond to exposure to oxidants that include hydrogen peroxide, paraquat, organic
peroxides, and diamide [6]. Genes that are transcriptionally active, directly or indirectly [7, 8], in
these conditions code for factors that detoxify ROS (e.g., kat and sod, ahpC, ahpF), confer
resistance to heavy metals (e.g., arsB), prevent protein misfolding (e.g., groES, dnaK), and
maintain thiol-disulfide homeostasis in the cell (trx, cys, bsh) [9, 10].
On the other hand, the prevention of oxidative damage to DNA is mediated by MutT,
MutM, and MutY proteins, altogether called the guanine oxidized (GO) system [11–14].
Guanine residues have the lowest reduction potential, which makes them a preferred substrate of
ROS. Oxidative damage of guanines results in the formation of an 8-oxoG (OG) lesion [15].
MutT, a nucleotide sanitizer, prevents ROS damage to DNA by avoiding the incorporation of
oxidized dGTPs and GTPs into nucleic acid molecules [11, 16]. MutM and MutY, DNA
glycosylases, function within the pathway known as the Base Excision Repair (BER) system
[17]. The MutM enzyme works as a DNA glycosylase that removes 8-oxoG from the backbone
of the DNA, which is subsequently replaced with an undamaged guanine by DNA PolI [14]. If
left unrepaired, 8-oxoG mispairs with adenine residues leading to transversion mutations. The
MutY glycosylase preferentially targets the 8-oxoG:A pair. MutY cleaves the adenine from the
sugar-phosphate backbone and produces an abasic site. Both MutM and MutY create an abasic
(AP) site. AP sites are the substrate for AP endonucleases which nick the DNA generating a 3’OH group upstream of the AP site. This reaction primes replication by a DNA polymerase which
ultimately replaces the mispaired residue. Finally, the repair reaction is sealed by ligase [3, 17,
18].
In conditions in which cells are non-dividing, ROS are proposed to be intermediates in
the formation of mutations that confer fitness [19]. This phenomenon is known as stationary-
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phase mutagenesis (SPM) [20]. One factor required for the generation of these adaptive
mutations in B. subtilis is the protein Mfd [21]. Mfd was first identified as the Transcription
Repair Coupling Factor (TRCF), which pairs the recognition of DNA damage by the RNAP to
repair by the NER pathway through the UvrABCD pathway [22]. Transcription-coupled repair
has been well-characterized in the context of high-fidelity DNA repair caused by UV damage.
Recent findings, however, showed that Mfd promotes SPM through the interplay with multiple
DNA repair pathways including the NER and BER systems [23]. This observation prompted us
to determine whether Mfd is involved in repair of DNA lesions caused by exogenous ROS. Our
research indicates that Mfd promotes repair of oxidative damage in B. subtilis and suggests that
oxidative damage is a precursor to stationary-phase mutagenesis. Interestingly, we found that
Mfd is involved in protecting cells against diamide, an oxidant that targets proteins. This
protection was independent of its interactions with the NER and BER pathways. Altogether,
these findings suggest that Mfd affects how the cell balances the potential evolutionary benefits,
such as mutagenesis, and cellular detriments presented by oxidative stress.

Results
Mfd protects B. subtilis cell viability after exposure to oxidative damage
To determine if Mfd protects against oxidative damage in stationary-phase B. subtilis
cells, we subjected YB955 (Mfd+) and YB9801 (Mfd−) to varying levels of oxidative stress by
exposing cells to the oxidant t-BHP. t-BHP is an organic peroxide that is metabolized by cells to
form multiple radicals that damage several cellular components, such as lipids and DNA [6, 24].
We found that the Mfd-deficient strain had decreased survival following exposure to this oxidant
agent (Fig. 3.1).
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Because Mfd is a component of the transcription-coupled NER (UvrABCD) pathway, we
tested if deficiencies in the Uvr pathway also affected the ability of the B. subtilis cells to
withstand ROS stress. The survival of all tested strains was increasingly affected by the oxidant
concentration. However, only the deficiency in Mfd led to significantly lower percent survival
than those observed in strains YB955 or YB9900 (UvrA−) (Fig. 3.1) and was recovered in a
complemented strain (Fig. 3.2). We also tested the effects of hydrogen peroxide on cell survival
as affected by Mfd and UvrA. The parental, Mfd−, and UvrA− strains were exposed to 60 mM
hydrogen peroxide for two hours during stationary phase, washed, and plated to determine
colony forming units. The percent survival for YB955 and UvrA− strains were similar and
significantly different from the survival shown by the Mfd− strain. Therefore, during the
stationary phase, the absence of Mfd greatly impacted the ability of B. subtilis tolerate this
hydrogen peroxide treatment (Table 3.3). As a control, we tested B. subtilis cells for their ability
to withstand UV (50 J/m2 UV-C); the UvrA− (YB9900) strain was severely impaired in survival
compared to the YB955 strain (Table 3.3).
Because the oxidative damage protection was unaffected in the UvrA− background
compared to the parental strain, we tested the possibility that Mfd was interacting with a
component of the GO pathway, specifically the DNA glycosylase MutY. We examined the
ability of strains deficient for Mfd or MutY to the noxious effects of t-BHP (Fig. 3.1).
Deficiencies in Mfd (YB9801) or MutY (PERM1029) led to significantly lower percent survival
than those observed in YB955 or YB9900 (UvrA−). Interestingly, the survival values displayed
by YB9801 (Mfd−) and PERM1029 (MutY−) were similar, which suggests that these two factors
combine to work as part of a pathway to prevent oxidative damage.
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We further tested the possibility that the combination of MutY and Mfd protected cells
during exposure to ROS. The t-BHP treatment showed that single inactivation of mfd or mutY led
to similar values in cell survival. Deficiencies in Mfd or MutY resulted in decreased survival
compared to the parental strain (Fig. 3.3). Of note, the double mutant mfd mutY showed lower
levels of survival than the strains carrying single mutations. This observation suggested that both
factors protected cells against oxidative stress additively; perhaps Mfd exerted an added
protection by a pathway independent of DNA repair.

Oxidative damage leads to stationary-phase mutagenesis in a Mfd- and MutY-dependent manner
The results from the cell survival experiments suggested that Mfd and MutY act
additively in preventing cytotoxicity. This observation prompted us to investigate whether Mfd
and MutY were important in genotoxicity in conditions of oxidative stress. We examined how
the absence of both proteins impacted mutagenesis under conditions of nutritional stress. MutY,
which targets OG:A and other A mismatches, was implicated in the formation of mutations in
stationary-phase cells of B. subtilis, particularly in the absence of the mismatch repair system
[18]. Thus, we examined the possibility that oxidative stress was activating a Mfd-MutY
protective system against DNA lesions that produce mutations. To measure mutagenesis, we
used strains that contained an isopropyl β-D-1 thiogalactopyranoside (IPTG)-inducible, pointmutated argF gene in genetic backgrounds with varying proficiencies of Mfd and MutY in our
stationary-phase mutagenesis assay [20]. After the cells had reached T90 (namely, 90 min after
the cessation of growth), cultures carrying the argF gene construct with defects in Mfd, MutY, or
both were split and placed in conditions that combine the presence and absence of IPTG (0.1
mM), and the presence and absence of t-BHP (1 mM) for two hours. After treatment, cells were
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washed twice, plated on two media: non-selective (to measure total CFU) and selective media
containing IPTG and no arginine (selective for Arg+), and counted for CFUs at daily intervals for
nine days of incubation.
Arg+ mutagenesis differed amongst the genetic backgrounds studied and ranged from 1 to
5 revertants per 107 cells independently of transcriptional induction (Fig. 3.4; A and B, day 9).
The wild-type strain and mfd mutant showed similar mutagenesis accumulation, but the mutY and
mutY mfd mutants were notably decreased in the accumulation of Arg+ revertants. In cells not
treated with t-BHP, mutY had greater influence than mfd on SPM, regardless of IPTG induction
of the argF mutant allele.
In conditions in which cells were previously exposed to t-BHP, mutagenesis was
strikingly increased as it ranged from 20 to 100 revertants per 107 cells at day 9 (Fig. 3.4 C). In
these conditions, transcriptional induction (+IPTG) increased the number of Arg+ revertants
produced by the wild-type strain (~ 60 to ~ 100 per 107 cells at day 9) (Fig. 3.4 D). The
mutagenesis values for the single and double mfd mutY mutants observed in conditions of
oxidative damage in the presence or absence of IPTG were similar. As controls, we conducted
fluctuation assays to estimate the mutation rate of Arg+ prototrophy (exponentially growing
cells) as affected by oxidative stress. We found no differences (in the range of 10-9 mutation per
cell generated) between the treated and untreated cells of the wild-type and mutants defective in
Mfd, MutY, or both (Table 3.4). Also, a control strain carrying the inducible promoter but no
argF yielded no mutants (data not shown), and the viability of the cells was not affected in the
different genetic backgrounds (Fig. 3.5). These results support the concept that Mfd and MutY
participate in a mutagenic pathway that takes place in growth-limited cells experiencing
oxidative stress, and that such pathway is promoted by transcriptional induction.
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Mfd, but not MutY, protects against disulfide stress
The experiments measuring cell survival after exposure to t-BHP in the double knock-out
(Fig. 3.3; Mfd- and MutY-) suggested the possibility that Mfd may have an added effect on cell
cytotoxicity in conditions of oxidative stress. We then examined whether Mfd prevented
cytotoxicity against oxidative damage that targets proteins and conducted experiments that
exposed cells to diamide, an oxidant that targets thiol groups and thus limits oxidative damage to
proteins [25, 26]. Surprisingly, cells of the strain YB9801 (Mfd-) were more sensitive to the
harmful effects of the protein oxidant than were the cells of the parental YB955 strain. However,
cells lacking MutY (PERM1029) behaved similarly to the parental strain cells and cells
containing an inducible Mfd construct survived substantially better (Fig. 3.6 and Fig. 3.7).
Therefore, we concluded that in addition to participating in TC-NER and now-documented role
in oxidative damage repair, Mfd is involved in protecting cells under stress conditions that
induce protein damage.

Mutagenesis in growing cells is unaffected by Mfd
We also tested the effects of these oxidants on mutagenesis in growing B. subtilis cells.
To this end, we determined the frequency of rifampin-resistant mutants in exponentially growing
cultures exposed to no exogenous oxidant, t-BHP, and diamide. The mutation frequency values
were statistically similar in the parental, Mfd−, UvrA−, and Mfd-restored strains (Table 3.5). The
mutation rate values for those strains in the presence and absence of oxidants ranged from a twofold increase to a three-fold decrease compared to the untreated strain YB955. The MutYdeficient strain showed a significant increase in the mutation frequency to rifampicin resistance
compared to the parent strain, even in the absence of exogenous oxidant. Of note, in the presence
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of either oxidant, the MutY- strain showed further increases in the RifR mutation frequency;
however, those increases were not significantly different from the untreated MutY- condition.
These results suggest that MutY prevents DNA lesions in growing cells. Such lesions may be
produced during respiration or when cells experience oxidative stress. These results are in stark
contrast to those observed in ArgF+ mutagenesis in stationary-phase cells. MutY was promutagenic and worked in combination with Mfd, which did not affect mutation frequency in
growing cells.

Mfd affects gene expression after exposure to oxidative stress in B. subtilis
To better understand the role of Mfd in the response to oxidative stress, we conducted
reverse transcription quantitative PCR (RT-qPCR) in cells differing in Mfd proficiency in
conditions of oxidative stress. We measured gene expression of ohrR and yodB, two genes that
encode for transcriptional factors that sense the redox state of the cell and derepress transcription
of genes that respond to t-BHP and diamide [27]. In conditions of oxidative stress, these two
repressors are oxidized at cysteine residues which results in derepression of genes that code for
detoxifying enzymes. We also measured the veg gene as a control to estimate fold-increase in
gene expression [28]. Stationary-phase cultures were split into no treatment or treatment with
either t-BHP or diamide for 2 h, subject to RNA isolation and assayed for RT-qPCR.
The wild-type and Mfd mutant cells displayed increased expression of ohrR in response
to a two-hour exposure to t-BHP; however, the increase shown by the two strains was markedly
different. While the wild-type cells showed a five-fold (±2.7) increase in ohrR expression, the
Mfd-deficient cells increased 35-fold (±5.9) the expression of this gene (Fig. 3.8 and Table 3.6).
The response observed in cells treated with diamide for two hours was not affected by the
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presence of Mfd, and both strains showed about two-and-half fold increased expression of yodB.
In summary, the RT-qPCR results suggest that Mfd perturbs gene expression of ohrR in cells
exposed to t-BHP, and that such perturbation leads to a maladaptation and decreased cell
survival. On the other hand, the Mfd effect on cell survival after exposure to diamide did not
operate through changes in expression of yodB, a regulator that derepresses gene expression
during exposure to diamide. These results suggest that deficiencies in Mfd compromise the
response to organic peroxides by increasing expression of the repressor OhrR; in contrast, Mfd
may be affecting the response to disulfide stress independently of changes in expression of the
YodB repressor.

Discussion
Here, we showed that Mfd protects against t-BHP-generated oxidative damage in B.
subtilis. First, the survival to t-BHP exposure and the Arg+ mutagenesis experiments revealed
that Mfd and MutY cooperate to repair of t-BHP damage to DNA. Our data provided evidence
that the role of Mfd in the processing of ROS is outside of the NER pathway. Instead, Mfd
interplays with components of the BER pathway, most specifically the DNA glycosylase MutY.
Further, our experiments showed that Mfd and MutY combined to form mutations, perhaps
through error-prone repair [23, 29, 30]. Interestingly, B. subtilis cells lacking MutM were
impaired in their ability to withstand treatments with hydrogen peroxide or paraquat but showed
an increase in the accumulation of mutations in stationary-phase cells [14]. This response
contrasts with the pro-mutagenic role of MutY observed here and elsewhere [23]. It is interesting
to note that AP sites, an intermediate formed during repair of oxidative lesions, were shown to be
mutagenic and cause the RNAP to stall in E. coli [31]. In humans, a recent report that used the
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SV40 immortalized cell line MRC-5 showed that oxidative damage and CS-B, a functional
homolog of Mfd, recruits BER repair factors during transcription [32]. Moreover, single-stranded
site gaps in Hela cells, generated during the repair of oxidative damage, blocked active RNAPII,
and recruited CS-B and transcription-coupled repair [33]. In B. subtilis, AP sites are subject to
error-prone repair that produces mutations in stationary-phase cells [29].
Because the Mfd-MutY interplay can occur in highly transcribed genes under selection
and in conditions in which error-prone polymerases are expressed, one could argue that this
process produces mutations with high adaptive potential. The interplay of Mfd and MutY may
not require direct protein-protein interactions which are needed between Mfd and NER [23]. An
indirect interaction may take place via a stalled RNAP that has encountered a MutY glycosylase
processing an 8-oxo-G base pairing. In this case, a MutY occupying a lesion site represents a
DNA-protein block to active RNAP elongation. Then, Mfd could dislodge the stalled RNAP
thereby making the lesion available for further processing. Evidence supporting a model in
which Mfd clears RNAP stalled by DNA-repressor complexes has been presented in B. subtilis
[34–36].
One interesting aspect of the stationary-phase mutagenesis results is the prolonged effect
of the transcriptional induction of the argF allele (two hours) and the t-BHP exposure (two
hours) on the accumulation of mutants over nine days. We speculate that this lasting effect on
mutagenesis is the potential result of processing an overwhelming number of DNA lesions
generated during the oxidant exposure. Another possibility is a slow rate of repair. Alternatively,
the combination of the exposure to the oxidant and the increased transcription leads to a DNAdamage-tolerance-like cellular state. Elucidating between these possibilities ought to be the
subject of future work.
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The reports on the protective role of Mfd against oxidative damage are different in other
experimental systems. In E. coli growing cells, there were no differences in survival to oxidative
damage between the parental strain and Mfd mutant [37]. Contrastingly, in experiments
measuring transcriptional bypass of oxidative damage in non-replicating E. coli cells, Mfd
prevented such event [38]. In nuclear extracts from Hela cells, the CS-B factor facilitated
transcriptional bypass of DNA templates containing 8-oxo-G lesions [39]. However, in vitro
experiments suggest that the E. coli RNAP transiently pauses at such sites but does not recruit
Mfd [40]. Recent biochemical evidence indicates that Mfd is important for repair of DNA lesions
that are positioned remotely downstream of a paused RNAP [41]. Thus, it is possible that in
stressed B. subtilis cells, when transcriptional profiles are very different from those observed in
growing conditions and the DNA replication machinery is less active [42–45], Mfd acts as a
factor that senses a wide variety of lesions. This would include those lesions that are not
recognized by the NER system or not known to block the RNAP. Previous reports support the
concept that Mfd is a factor that maintains genome integrity in growing cells [46, 47]. However,
our experiments indicate that this factor also warrants the production of genetic diversity in times
of stress, particularly when ROS and organic peroxides are increased.
The experiments using different types of oxidants lend support to the concept that Mfd
protects the cell from organic peroxides by facilitating gene expression of factors that deactivate
such compounds; this is unprecedented. B. subtilis activates different regulons to counter the
effects of ROS [6]. However, our experiments focused on exposure of cells to an organic
peroxide and a protein crosslinker. Exposure to diamide results in modification of the cellular
proteome [48]; proteins with cysteine residues are sensitive to disulfide bond formation [49]. The
results observed after treatment with diamide prompted us to examine the effect of Mfd on gene

56

expression. Treatment with t-BHP results in gene derepression of ohrA, which codes for an
organic hydroperoxide detoxifier. Transcriptional activation of ohrA is controlled by the
repressor OhrR [10, 24, 50]. This repressor in its reduced state occludes the promoter region of
ohrA and prevents its transcription. Oxidation of OhrR at the thiol group in residue C15 proceeds
through formation of a sulfenic acid intermediate that retains DNA binding activity. However,
further S-thiolation or formation of sulfonamide, sulfinic or sulfonic acid renders OhrR inactive
and derepression ensues [51]. Defects in Mfd resulted in a 35-fold increase in expression of the
ohrR. Based on these results, it is tempting to speculate that the associated increase in gene
expression, observed in the absence of Mfd, precipitates an increased concentration of OhrR and
a subsequent increase of the intermediate that retains repressor activity. Thus, in the presence an
increased amount of active repressor, expression of detoxifying factors would be limited and lead
to increased sensitivity to t-BHP in Mfd− cells. This pattern was not observed in the experiments
that exposed cells to diamide, which suggests that Mfd is affecting gene expression of factors
that control thiol homeostasis independently of a transcriptional effect on YodB, a repressor that
controls the response to diamide.
Our understanding of how Mfd functions has focused on DNA repair; however, there is
mounting evidence indicating that its functions go beyond DNA repair. In B. subtilis, Mfddeficient cells are less efficient in endospore formation [52], are affected in repression of genes
that are under the controlled of catabolite repression [34, 35] or amino acid starvation [53].
Recently, single-molecule resolution experiments demonstrated that Mfd can interact with
RNAP and translocate along DNA independently of its interactions with other repair proteins.
Those results led the authors to postulate that Mfd modulates transcription via a catch-andrelease mechanism [54]. This concept is congruent with what we observed in the experiments
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that exposed cells to diamide. Those experiments showed an Mfd effect that was independent of
UvrA and MutY. We propose that future work use an unbiased transcriptomics approach, such as
RNA-Seq, to investigate the effect of Mfd on transcription genome wide.
Furthermore, recent work has shown the importance of Mfd in the biology of multiple
pathogens. Willing et al. showed that a Clostridiodes difficle mfd mutant had increased toxin
production [55]. In Staphylococcus aureus, inactivation of Mfd was associated with decreased
biofilm formation [56]. In Helicobacter pylori, Mfd is required for decreased sensitivity to
antibiotics. Based on those observations and the results presented here, we postulate that Mfd
functions as factor that protects against DNA lesions caused by oxidative damage and as a factor
that modulates transcription in stressed cells. Thus, one significant implication of this study is
that it proposes Mfd as a novel and attractive target to inhibit evolution of antibiotic resistance
and to mitigate gene expression of bacterial virulence factors.

Conclusions
This work indicates a role for Mfd in stressed B. subtilis cells tolerance to oxidative
damage. First, it was demonstrated that Mfd protects against oxidative damage to DNA.
Secondly, it was determined that this protection is through its interactions with MutY. Further,
Mfd and MutY work cooperatively to generate mutations in stressed B. subtilis cells. Finally,
Mfd protects against oxidative damage to proteins. The protection from the protein oxidant
diamide was independent of DNA repair pathways associated with Mfd’s known functions.
Thus, Mfd functions beyond transcription-coupled repair.
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Methods
Strains
YB955 is a B. subtilis 168 strain containing point mutations in genes for amino acid
biosynthesis of histidine (hisC952), methionine (metB5), and leucine (leuC427) [20]. Genetic
transformation of YB955 with antibiotic resistance gene cassettes created strains with
deficiencies in Mfd, MutY, UvrA, and the double knockout Mfd/MutY. Transformations were
carried out as described previously [57].
To measure mutagenesis, we used a background deficient in argF. A deletion of argF
was constructed which contained a neomycin cassette. This background also included placing a
point-mutated argF downstream of the Phs promoter (IPTG-inducible) which was recombined
into the amyE chromosomal locus. The CV1000 strain was constructed by transforming a
Phyperspank (pDR111) plasmid carrying the argF gene with a stop codon into Bacillus subtilis.
Transformants were selected on Tryptose Blood Agar Base (TBAB) (BD, Sparks, MD) plates
with 100 μg/ml of spectinomycin and screened for arginine auxotrophy. The TAA stop codon
replaces the CAA codon at position 37 in the ArgF protein. The TAA stop codon was engineered
into the argF sequence through PCR mutagenesis.
In brief, primer CV1000–1 was designed with an amber stop codon TAA and used in
combination with WT argF reverse primer CV1000–2 carrying a SphI restriction site in PCR
reactions containing Vent Polymerase. This reaction product was then used as a template for a
second Vent PCR reaction using forward primer CV1000–3 and the same WT argF reverse
CV1000–2 primer. This PCR product was then combined with an upstream region of argF for
fusion. The two PCR products were mixed at a 1:1 ratio and all PCR reagents were added to the
mixture excluding primers and GoTaq polymerase. Denaturing/annealing cycles were
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programmed to go on for 7 cycles to allow for hybridization of the two templates, Gotaq
polymerase and primers WT argF For CV1000–4 carrying a SalI restriction site and WT argF
Rev. CV1000–2 were then added to the mixture and the reaction continued for 20 cycles. The
PCR products were then resolved on 1% Agarose gel and fragments corresponding to 1.2 kb size
were excised out of the gel and cleaned up using the Qiagen MinElute Gel Extraction Kit (Venlo,
Netherlands). The cleanup product was then digested using SalI and SphI enzymes (New
England Biolabs, Ipswich, MA), ligated to the Phyperspank plasmid, and transformed into B.
subtilis as described previously [57]. This construct integrated into the amyE region of the
genome as confirmed by PCR.
Strains CV1001, CV1002, and CV1003 (Mfd−, MutY−, and Mfd−MutY−, respectively) are
derivatives of CV1000. These strains were constructed by transforming genomic DNA from
YB9801 and PERM1029. CV1004 was constructed by transforming Phyperspank plasmid into
the YB955 arg::neo background. All strains are defined in Table 4.1.

Preparation of oxidant solutions
This oxidative stress assay required the preparation of a stock solution of the oxidizing
agent. It is important to note that preparation of an oxidizer stock is affected by water quality; the
metal content in the water significantly reduces the strength of the oxidant. A sterile glass bottle
was acid washed using 1 N hydrochloric acid, allowed to dry, and then re-autoclaved for
sterilization. The bottle was filled with DI water and autoclaved again. To make a 1M tert-butyl
hydroperoxide (t-BHP) (Sigma Aldrich, St. Louis, MO) stock solution, two sterile
microcentrifuge tubes were placed on ice. 871.8 μl of the previously sterilized DI water was
placed into one microcentrifuge tube. In the second separate microcentrifuge tube, 200 μl of t-
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BHP were added. From the 200 μl aliquot of t-BHP, 128.2 μl were transferred into the 871.8 μl
of DI water.
To create a 1M diamide (Sigma Aldrich, St. Louis, MO) stock solution, one sterile
microcentrifuge tube was placed in ice and filled with 1 ml of the sterile DI water. 172 mg of
diamide was transferred into the microcentrifuge tube containing the DI water and vortexed until
diamide fully dissolved. It is important to note that we were careful with the use of oxidant
preparations as we have observed increased variation in the response in cell survival as a
function of time. We used fresh preparations from stocks that were less than 3 months-old from
the date of purchase. Also, our replicate trials were conducted within one week. In spite of these
efforts, we did observe variations in cell survival; however, trends in the response by a specific
strain held up across experiments.

Cell treatment with oxidants
Cells were grown in two ml of Penassay Broth (PAB) (BD, Sparks, MD) overnight in a
shaking incubator at 37 °C and 250 rpm. One ml of an overnight culture was transferred into 20
ml of fresh PAB containing 20 μl of 1X Ho-Le trace elements [58] into 125 ml flasks. Growth
was tracked using a spectrophotometer measuring optical density (OD600) (ThermoFisher
Scientific, Waltham, MA). When cells reach 90 min past the onset of stationary phase (T90), two
ml of culture was transferred into five, 13mm test tube. t-BHP or diamide was then dispensed at
different concentrations (0 mM, 0.5 mM, 1.0 mM, 1.5 mM, 2.0 mM). While being exposed to
oxidants, the cells were incubating with aeration at 37 °C and 250 rpm for two hours. Following
incubation, one ml was removed from each of the 13mm test tubes, centrifuged at 13,000 rpm for
two minutes, and resuspended in 1X Spizizen Minimal Salts (SMS) [59]. Cells were washed
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again and resuspended in 1X SMS to remove residual oxidant. The resuspended culture was
serially diluted in 10-fold and 0.1 ml of the final dilution was plated onto TBAB. Plates were
incubated for 24 h at 37 ° C and scored for colonies to determine survival.

Stationary phase mutagenesis assay
Cells for this assay were prepared exactly as those subjected to the survival assays. One
ml of an overnight culture was inoculated into a culture flask with 20 ml of PAB supplemented
with 20 μl trace elements. Cultures were grown with aeration in an incubator at 37 °C and 250
rpm to T90. Growth tracked with a spectrophotometer measuring optical density (OD600). 2 ml
of the culture were transferred into four, 13mm test tube. Each test tube was subjected to a
specific condition of oxidative damage and transcriptional induction for two hours. Cells were
then washed twice with 1X SMS.
Aliquots of 0.1 ml were spread plated in quintuplicate on Spizizen minimal medium
(SMM) containing 1× SMS, 0.5% dextrose, 50 μg/ml isoleucine, 50 μg/ml glutamate, 1.5% agar
(ThermoFisher Scientific, Waltham, MA), 50 μg/ml of histidine and methionine, and a 50 μg/ml
leucine (Sigma-Aldrich, St. Louis, MO), with 1mM IPTG. The plates were incubated for nine
days at 37 °C. Every 24 h, were observed for the appearance of Arg+ colonies. To determine the
number of cells plates, titers of the B. subtilis cultures were measured by serially diluting the
resuspended culture and plating on TBAB.
To assay the non-revertant background cells, the viability of these cells was tracked over
the nine-day period. Every odd day, a plug of agar was removed from a colony-free area of each
of the five plates. This was done for each condition previously mentioned. The plugs were placed
in 500 μl of 1X SMS, serially diluted, and plated in triplicate on SMM containing 50 μg/ml
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arginine, leucine, methionine, and histidine. Colonies were observed after 48 h of incubation.
This stationary phase mutagenesis assay was originally described by Sung and Yasbin [20].

Fluctuation tests
The growth-dependent mutation rate for arginine prototrophy was measured by
fluctuation tests with the Lea-Coulson formula, r/m-ln(m) = 1.24 [60]. During the second
overnight growth in PAB, cultures were grown in the presence or absence of 0.5 mM diamide,
0.5 mM t-BHP, and 1 mM IPTG. Three parallel cultures were used to determine the total number
of CFU plated on each plate by titration. The mutation rates were calculated as previously
described with the formula m/2Nt [20, 60].

Quantitative real-time PCR
Cells for this assay were grown as described above. Two ml of an overnight culture was
inoculated into a culture flask with 50 ml of PAB supplemented with 50 μl trace elements.
Cultures were grown with aeration in an incubator at 37 °C and 250 rpm to T90. Growth tracked
with a spectrophotometer measuring optical density (OD600). Then, the cultures were divided in
half and grown for an additional two hours. One half of the culture was exposed to 1mM t-BHP
or diamide. Cells were then pelleted, and RNA was extracted using the RiboPure Bacteria Kit
(Ambion, Carlsbad, CA). Using the One-Step SYBR GREEN RT-qPCR kit (Quanta,
Biosciences, Beverly, MA), the isolated mRNA was reverse transcribed and amplified for realtime PCR. The 25 μL reactions contained the master mixes of One-Step SYBR Green RT-qPCR
containing 50 ng of RNA and 300 nM final concentration of the appropriate primers (listed in
Table 3.2). With the veg gene servicing as the internal control, three replicates from each culture
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condition were assayed and normalized [61, 62]. Reactions with no reverse transcriptase and notemplate, respectively, served as controls. These reactions were run on a Bio-Rad iCycler iQ
Real-Time PCR Detection System (Bio-Rad, Hercules, CA, USA), using the manufacturer’s
suggested protocol and an annealing temperature of 60 °C. Results were calculated by the 2-ΔΔCT
(where Ct is threshold cycle) method for relative fold expression [63].

Statistical analysis of data
Statistical analysis was conducted with the SPSS software. Data from survival
experiments testing t-BHP and diamide were entered in a SPSS spreadsheet using two variables.
Each of the strains tested was designated as a single level within the independent variable. The
values for the dependent variable consisted of the survival values. Within the analyze module of
SPSS, we used the compare means program to run one-way analysis of variance (ANOVA) an α
significance of P < 0.05. We coupled the one-way ANOVA with post hoc multiple comparisons
of means. To determine whether two means were significantly different, we used the least
significant difference test (LSD) at P < 0.05 in SPSS. This test calculates a critical value between
two means. If the difference between two means is higher than the critical value, then the tested
means are significantly different. The formula to calculate the value of the LSD is: LSDA,B =
(t0.05/2 DFW) x √((MSW) x (1/nA + 1/nB)). The formula uses the t-distribution (two-tail), the
degrees of freedom for within groups in the ANOVA table (DFW), the mean square value of the
within groups in the ANOVA table (MSW), and the number of observations for each of the
means (n). We used a letter system to denote significant differences between means. We
assigned “a” to the means that were not significantly different from the mean with the with the
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highest value, “b” to means that were different from the “a” group, and so on. Data from
mutagenesis experiments were processed in SPSS similarly.

Figures & Tables
Table 3.1. Strains and plasmids used in this study.
Strain Name

Relevant genotype

Reference or Source

YB955

hisC952 metB5 leuC427

20

YB9801

hisC952 metB5 leuC427 mfd::tc

21

PERM1029

hisC952 metB5 leuC427 mutY::em

23

PERM1134

hisC952 metB5 leuC427 mfd::tc amyE::phs-mfd
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PERM818

hisC952 metB5 leuC427 mutY::em mfd:;tc

23

YB9900

hisC952 metB5 leuC427 uvrA::sp

23

hisC952 metB5 leuC427 argF::neo amyE::pHSCV1000

Constructed for this work
argSP
hisC952 metB5 leuC427 argF::neo mfd::tc

CV1001

Constructed for this work
amyE::pHS-argFSP
hisC952 metB5 leuC427 argF::neo mutY::em

CV1002

Constructed for this work
amyE::pHS-argFSP
hisC952 metB5 leuC427 argF::neo mfd::tc

CV1003

Constructed for this work
mutY::em amyE::pHS-argFSP

CV1004

hisC952 metB5 leuC427 argF::neo amyE::pHS
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Constructed for this work

Table 3.2. Primers utilized in this study.

a

Primer

Sequencea

CV1000–1

GGTGAGCTGAAATAAAACAAAATTCAGCCTTAGTAT

CV1000-2

ACCAGCATGCCCTCCTTTTTGCTGTAGTAT

CV1000–3

TAAACGCCTTGCTCGCAGAAGCCGGTGAGCTGAAATAAAACAAA

CV1000–4

GATGTCGACTAAAAAGGAAGTGGCATCATGCACACAGTGACGCAA

CV1000–5

ACCAGAATGCCCTCCTTTTTGCTGTAGTATGC

F sigB

GATGAAGTCGATCGGCTCATAAG

R sigB

AACGATTTGCCGACAACAGG

F veg

GGCGAAGACGTTCGATA

R veg

CAGCTCAACAGTCTCAGTCA

F mutY

AAGGGCTCGGCTATTATTCGC

R mutY

TCCTGGACATGACACGCATC

F perR

AGGAAACCGGAGTTCGCATT

R perR

CTGCTGGAAGCATCACCGTA

F ohrR

ACAAAGCAATACAAGCCGCTG

R ohrR

GGACCGCTCATCCTCTTCAG

F yodB

GGGCCGAAACGGTTTAAAGA

R yodB

AAATTGATCGGCCCATGCCT

F mfd

GAGAAGCGAGCAAGGGCTAT

R mfd

CTTAAACGCACGTATGG

Underlined sequences indicate restriction sites introduced for cloning purposes
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Figure 3.1. Percent cell survival, displayed on a log scale, in the parental strain (YB955) and
cells deficient in the UvrA (YB9900), Mfd (YB9801), or MutY (PERM1029) respectively,
following exposure to ROS via the oxidizing agent tert-butyl hydroperoxide (t-BHP). Percent
survival of each strain was determined by dividing the number of colonies from each of the test
concentrations by the number of colonies observed at 0 mM t-BHP. Means are shown for each
strain. The error bars represent standard error. Means were compared using the SPSS software
package and one-way ANOVA. To establish whether two means were significantly different, we
used the least significant difference (LSD) test (P < 0.05) between SPSS package. Lower case
letters were used to denote significant differences between means. “a”, “b”, and “c” are
significantly different mean groups. ANOVA and LSD tests were conducted within each of the tBHP concentrations. These experiments were replicated four times, and each replicate
experiment comprise of three repetitions. The total number of observations is 12.
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Figure 3.2. Percent cell survival of the wild-type (YB955), Mfd-deficient (YB9801), and the
Mfd complemented (PERM1134) strains following exposure to ROS via the oxidizing agent tertbutyl hydroperoxide (1 mM t-BHP). Percent survival for each strain was determined by dividing
the number of colonies from of the test concentration by the number of colonies observed in the
no treatment control. Means and standard errors are presented. The graph shows an average of
three independent trials. Each independent trial included three repetitions.
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Table 3.3. Survival to hydrogen peroxide and UV-C in B. subtilis strains with defects in
components of the base excision repair and the nucleotide excision repair system.
A
Strain

60mM H2O2

YB955 (wild-type)

30+2%

YB9801 (Mfd-)

1.5+2%

YB9900 (UvrA-)

36+2%

B
Strain

UV-C (50 J/m2)

YB955

26.0+1.2

MutY- (PERM1029)

31.0+1.7

Mfd- (YB9800)

9.5+1.0

UvrA- (YB9900)

0.1+0.01

A) Percent cell survival of the wild-type (YB955), Mfd-deficient (YB9801), MutY-deficient
(PERM1029), and UvrA-deficient (YB9900) strains following exposure hydrogen peroxide.
Strain cultures were grown to T90, split in two aliquots, exposed to 60 mM hydrogen peroxide for
two hours, washed twice in an equal volume of 1X SMS, serially-diluted and plated to determine
CFU. Percent survival for each strain was determined by dividing the number of colonies from of
the test concentration by the number of colonies observed in the no treatment control. B) Percent
survival to UV-C exposure. Cells were grown to T90. Then, 20 ml of the cell suspension were
harvested, washed and resuspended in an equal volume of 1X SMS and dispensed onto a petri
plate. A one-ml aliquot was extracted and serially diluted and plated on TBAB to determine
CFU/ml. The remaining cells were exposed to 50 J/m2 of UV-C. Percent survival was estimated
by dividing the number of CFU after UV-C exposure by the number of unexposed CFU. The
UvrA- strain (YB9900) was severely impaired in survival compared to the YB955 and MutY(PERM1029) strain. The table shows the mean and standard error for each strain. The
experiments were replicated three times.
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Figure 3.3. Percent cell survival, displayed in log scale, in the parental strain (YB955) and cells
containing single and double defects in Mfd and MutY, (YB9801, PERM1029, and PERM818,
respectively), following exposure to tert-butyl hydroperoxide (t-BHP). Percent survival of each
strain was determined by dividing the number of colonies from each of the test concentrations by
the number of colonies observed in the no treatment. Means are shown for each strain. The error
bars represent standard error. Means were compared using the SPSS software package and oneway ANOVA. To establish whether two means were significantly different, we used the least
significant difference (LSD) test (P < 0.05) between SPSS package. Means with the same letter
are not significantly different. ANOVA and LSD tests were conducted within each of the t-BHP
concentrations. These experiments were replicated four times, and each replicate experiment
comprise of three repetitions. The total number of observations is 12.
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Figure 3.4. Accumulation of Arg+ mutations over nine days in the wild-type CV1000 strain and
strains deficient in Mfd (CV1001), MutY (CV1002), or both (CV1003) when (a) no treatment,
(b) induction with IPTG for two hours, (c) treatment with 1mM t-BHP for two hours, or (d)
induction with IPTG and treatment with 1mM t-BHP for two hours. The line on each section is at
the 5 revertants per 107 CFU for easier comparison. Means are shown for each strain. The error
bars represent standard error. Means were compared using the SPSS software package and oneway ANOVA. To establish whether two means were significantly different, we used the least
significant difference (LSD) test (P < 0.05) between SPSS package. Lower case letters were used
to denote significant differences between means. “a”, “b”, and “c” are significantly different
mean groups. ANOVA and LSD tests were conducted separately for each day after plating.
These experiments were replicated three times, and each replicate experiment comprise of five
repetitions. The total number of observations is 15.
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Table 3.4. Arg+ reversion rates for CV1000 (wild-type), CV1001 (Mfd−), CV1002 (MutY−), and
CV1003 (Mfd− MutY−) as affected by exposure to the oxidants tert-butyl hydroperoxide (t-BHP)
or diamide.
Strain

Condition

Mutation Rate

C.L.

CV1000

Arg-

5.01E-09

1.689E-09

CV1000

Arg- + IPTG

6.73E-09

1.56E-09

CV1000

Arg- + Diamide

5.17E-09

1.56E-09

CV1000 Arg- + Diamide/IPTG

1.68E-08

9.16437E-10

CV1000

Arg- + t-BHP

8.43E-09

2.2E-09

CV1000

Arg- + t-BHP/IPTG

2.27E-08

7.3E-10

CV1001

Arg-

3.81E-09

1.23E-09

CV1001

Arg- + IPTG

8.41E-09

1.23E-09

CV1001

Arg- + Diamide

7.87E-09

9.8E-10

CV1001 Arg- + Diamide/IPTG

1.38E-08

1.93E-08

Cv1001

Arg- + t-BHP

1.54E-08

1.88E-08

CV1001

Arg- + t-BHP/IPTG

1.89E-08

1.74E-08

CV1002

Arg-

5.11E-09

2.36E-09

CV1002

Arg- + IPTG

3.29E-09

1.79E-09

CV1002

Arg- + Diamide

3.20E-09

1.33E-09

CV1002 Arg- + Diamide/IPTG

1.05E-08

1.56E-08

CV1002

Arg- + t-BHP

4.41E-09

1.74E-09

CV1002

Arg- + t-BHP/IPTG

1.03E-08

2.26E-08
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CV1003

Arg-

3.32E-09

1.33E-09

CV1003

Arg- + IPTG

3.55E-09

1.50E-09

CV1003

Arg- + Diamide

5.48E-09

1.41E-09

CV1003 Arg- + Diamide/IPTG

4.08E-09

1.74E-09

CV1003

Arg- + t-BHP

8.85E-09

2.00E-09

CV1003

Arg- + t-BHP/IPTG

1.65E-08

1.97E-08

Data were analyzed using one-way ANOVA at P < 0.01. To determine significance between
rates of mutations, we compared each rate to the untreated YB955 rate using the LSD test. There
were no statistically significant differences between rates.
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Figure 3.5. Viability of the wild-type (CV1000), Mfd-deficient (CV1001), MutY-deficient
(CV1002), and double mutant (CV1003) cells over the nine-day SPM presented in Figure 3.4.
Procedure of how viability was measured is described in materials and methods. Each point
represents an average of five samples. This is a representative figure for all four conditions
(induced, uninduced, treated with t-BHP, and untreated with t-BHP).
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Figure 3.6. Percent cell survival, displayed in log scale, of the wild-type (YB955), Mfd-deficient
(YB9801), MutY-deficient (PERM1029), and the Mfd complemented (PERM1134) strains
following exposure to the oxidizing agent diamide. Percent survival for each strain was
determined by dividing the number of colonies from of the test concentration by the number of
colonies observed at the no treatment control. Means are shown for each strain. The error bars
represent standard error. Means were compared using the SPSS software package and one-way
ANOVA. To establish whether two means were significantly different, we used the least
significant difference (LSD) test (P < 0.05) between SPSS package. Lower case letters were used
to denote significant differences between means. “a”, “b”, and “c” are significantly different
mean groups. These experiments were replicated four times, and each replicate experiment
comprise of three repetitions. The total number of observations is 12.
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Figure 3.7. A) Percent cell survival, displayed in log scale, in parental cells (YB955) and cells
containing a defect in Mfd (YB9801) or MutY (PERM1029) following exposure to the oxidizing
agent diamide. Percent survival for each strain was determined by dividing the number of
colonies from each of the test concentrations by the number of colonies observed at the no
treatment control. Means are shown for each strain. The error bars represent standard error.
Means were compared using the SPSS software package and one-way ANOVA. To establish
whether two means were significantly different, we used the least significant difference (LSD)
test (P < 0.05) between SPSS package. Lower case letters were used to denote significant
differences between means. “a”, “b”, and “c” are significantly different mean groups. ANOVA
and LSD tests were conducted within each of the diamide concentrations. These experiments
were replicated four times, and each replicate experiment comprise three repetitions. The total
number of observations is 12. B) Percent cell survival, displayed in log scale, in parental cells
(YB955) and cells containing a defect in Mfd (YB9801) or UvrA (YB9900) following exposure
to 1 mM diamide. Percent survival for each strain was determined by dividing the number of
colonies from each of the test concentrations by the number of colonies observed at the no
treatment control. The graph shows means and standard errors for three independent trials each
independent trial included three repetitions.
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Table 3.5. RifR mutation rates for YB955 (parental), YB9801 (Mfd-), YB9900 (UvrA-),
PERM1029 (MutY-), and PERM1134 (Mfd complemented) as affected by exposure to oxidants
tert-butyl hydroperoxide (t-BHP) or diamide.
Strain

Oxidant

Mutation Rate

Ratio to YB955 Control

YB955

Control

7.05E-9±2.7

1.0

YB955

t-BHP

4.46E-9±3.5

0.6

YB955

Diamide

1.38E-8±0.4

2.0

YB9801

Control

1.23E-8±0.4

1.7

YB9801

t-BHP

5.18E-9±2.2

0.7

YB9801

Diamide

9.35E-9±1.7

1.3

YB9900

Control

9.84E-9±2.1

1.4

YB9900

t-BHP

2.00E-9±0.9

0.3

YB9900

Diamide

1.49E-9±0.9

2.1

PERM1029

Control

1.76E-8±1.1*

2.5

PERM1029

t-BHP

3.42E-8±1.2*

4.8

PERM1029 Diamide

3.86E-8±1.1*

5.5

PERM1134

Control

1.03E-8±0.2

1.5

PERM1134

t-BHP

5.23E-8±3.5

0.7

7.09E-9±2.6

1.0

PERM1134 Diamide

Data was analyzed using ANOVA which showed significance (P< 0.01) between treatments. To
determine which means were significantly different from the control, means of treatments were
compared to the YB955 control mean using the LSD test. * represents statistically significant
differences between means.

77

Figure 3.8. Effect of Mfd on gene expression after exposure to t-BHP or diamide. a) Foldchange in ohrR mRNA expression after two-hour exposure to 1mM t-BHP in the parental strain
(YB955) and the mfd mutant (YB9801). b) Fold-change in yodB mRNA expression after twohour exposure to 1 mM diamide in the parental strain (YB955) and the mfd mutant (YB9801).
Fold-change in expression was calculated using the 2-ΔΔCt method. Means and standard error are
presented. The veg gene was used as the control. Each condition was replicated three
independent times. For a) and b), there were three technical replicates for each condition (total n
= 9).
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Table 3.6. Ct values from RT-qPCR assays of veg and ohrR genes (A) and veg and yodB (B)
from the parental strain (YB955) and the mfd mutant strain (YB9801) with (*) and without
exposure to 1 mM t-BHP (A) or diamide (B) for two hours.
A

veg

ohrR

Sample

Ct1

YB955 1

14.15 14.21 14.24 14.18

YB955 1

22.13 22.49 22.75 22.13

YB955 1*

10.96 11.37 11.52 11.28

YB955 1*

17.84 18.03 18.42 18.09667

YB955 2

13.1

YB955 2

23.04 22.93 22.76 22.91

YB955 2*

11.68 11.51 11.9

YB955 2*

19.02 18.94 19.36 19.10667

YB955 3

11.34 11.48 12.05 11.41

YB955 3

23.17 23.18 23.12 23.17

YB955 3*

11.56 11.35 11.42 11.44

YB955 3*

19.45 19.89 19.76 19.7

YB9801 1

10.8

YB9801 1

22.43 22.43 22.31 22.39

Ct2

Ct3

Avg. Ct Sample

13.25 12.45 12.93
11.70

10.66 10.75 10.74

Ct1

Ct2

Ct3

Avg. Ct

YB9801 1* 13.25 13.88 13.35 13.49

YB9801 1* 20.41 20.09 19.69 20.06333

YB9801 2

YB9801 2

9.89

YB9801 2* 10.2
YB9801 3

9.29

9.98

9.59

10.32 11.13 10.55

11.26 11.73 11.31 11.43

YB9801 3* 14.02 14.34 13.85 14.07

22.21 22.08 23.31 22.21

YB9801 2* 17.14 17.33 18.28 17.58333
YB9801 3

24.29 24.08 24.26 24.21

YB9801 3* 22.65 21.78 21.67 22.03333
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B

veg

yodB

Sample

Ct1

YB955 1

20.45 21.23 19.73 20.47

YB955 1

27.98 30.55 27.29 28.61

YB955 1*

19.89 16.54 17.98 18.14

YB955 1*

26.69 28.62 29.6

28.30

YB955 2

20.44 22.95 25.53 22.97

YB955 2

36.47 31.27 32.1

33.28

YB955 2*

21.13 18.33 18.34 19.27

YB955 2*

29.79 28.35 29.03 29.06

YB955 3

22.1

YB955 3

30.00 26.91 35.06 30.66

YB955 3*

17.53 17.57 19.24 18.11

YB955 3*

24.95 24.77 23.67 24.46

YB9801 1

16.31 16.49 16.05 16.28

YB9801 1

25.58 25.67 26.08 25.77

Ct2

Ct3

Avg. Ct Sample

21.05 20.31 21.15

Ct1

Ct2

Ct3

Avg. Ct

YB9801 1* 14.81 13.49 14.81 14.37

YB9801 1* 26.43 22.44 22.97 23.95

YB9801 2

YB9801 2

15.66 16.33 15.68 15.89

24.82 26.24 25.37 25.48

YB9801 2* 15.86 17.11 14.63 15.87

YB9801 2* 22.13 21.35 26.04 23.17

YB9801 3

YB9801 3

17.5

17.67 18.47 17.88

YB9801 3* 19.35 17.79 19.48 18.87

27.39 25.06 24.99 25.81

YB9801 3* 24.69 26.34 26.39 25.81
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CHAPTER 4
THE BACILLUS SUBTILIS K-STATE PROMOTES STATIONARY-PHASE
MUTAGENESIS VIA OXIDATIVE DAMAGE
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Forward
The previous chapter highlights the importance of oxidative damage in the formation of
stationary-phase mutations. Using genetic knockout strains and point mutation reversion assays,
I observed that Mfd and MutY work together to promote the accumulation of mutations in
stressful conditions. This mutagenic process was potentiated by transcription of the allele under
selection and exposure to oxidative damage. Furthermore, the previous chapter revealed an
unprecedented role of Mfd when cells were exposed to two different oxidants. Mfd protected
against protein oxidation! This protection was independent of the involvement of Mfd in its
canonical role in DNA repair. I speculate that Mfd modulates gene expression of factors that
protect against the noxious effects of disulfide stress.
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Prompted by the increased mutagenesis observed in cells experiencing oxidative stress and
the formation of differentiated cell subpopulations when B. subtilis encounters stress, I
investigated the possibility that a sub-population of hypermutable cells contributes to the
phenomenon of stationary-phase mutagenesis. The development of competence, also known as
the K-state, was demonstrated to promote stationary-phase mutagenesis independently of DNA
uptake. Interestingly, the K-state activates detoxifying mechanisms. Therefore, I examined the
influence of oxidative stress and the K-state, particularly the formation of a functional
competence pore, in the formation of stationary-phase mutagenesis. Using genetic knockout
strains, a point mutation reversion assay, and a fluorescent dye that responds to oxidative
damage, I found that the ability of K-cells to form a functional competence pore lead to an
increase in the number of stationary-phase mutations and oxidative cell damage. However, when
examining cell viability following oxidant exposure, cells with a functional competence pore
were sensitized to oxidant exposure. Therefore, these chapters describe the involvement of Mfd
in protection against oxidative stress and in mutagenic processes of stressed Bacillus subtilis
cells.

Abstract
Bacterial cells develop mutations in the absence of cellular division through a process
known as stationary‐phase or stress‐induced mutagenesis. This phenomenon has been studied in
a few bacterial models, including Escherichia coli and Bacillus subtilis; however, the underlying
mechanisms between these systems differ. For instance, RecA is not required for stationaryphase mutagenesis in B. subtilis like it is in E. coli. In B. subtilis, RecA is essential to the process
of genetic transformation in the subpopulation of cells that become naturally competent in
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conditions of stress. Interestingly, the transcriptional regulator ComK, which controls the
development of competence, does influence the accumulation of mutations in stationary phase in
B. subtilis. Since recombination is not involved in this process even though ComK is, we
investigated if the development of a subpopulation (K‐cells) could be involved in stationary‐
phase mutagenesis. Using genetic knockout strains and a point‐mutation reversion system, we
investigated the effects of ComK, ComEA (a protein involved in DNA transport during
transformation), and oxidative damage on stationary-phase mutagenesis. We found that
stationary‐phase revertants were more likely to have undergone the development of competence
than the background of non‐revertant cells, mutations accumulated independently of DNA
uptake, and the presence of exogenous oxidants potentiated mutagenesis in K‐cells. Therefore,
the development of the K‐state creates conditions favorable to an increase in the genetic diversity
of the population not only through exogenous DNA uptake but also through stationary‐phase
mutagenesis.

Contribution Statement
I am the sole first author of this publication.

Introduction
For over 60 years, genetic experiments have shown that bacterial cells can develop
mutations in the absence of growth; this is known as stationary‐phase mutagenesis or stress‐
induced mutagenesis [1–3]. This type of mutagenic processes is independent of growth and is
observed in bacteria and eukaryotes. Therefore, they expand our view of the evolutionary
process and can explain the formation of mutations that confer antibiotic resistance and cancers
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[1]. However, the cellular mechanisms governing this ability to undergo mutagenesis during
stress remain unclear, particularly in bacterial models other than Escherichia coli. One
interesting question in the stationary‐phase mutagenesis field is how a bacterial population
manages increases in genetic diversity without increasing the chance for genetic load. In this
regard, research has examined two aspects: (1) whether all the cells in a population are subject to
mutagenesis, and (2) whether all the genome is subject to mutagenesis. In E. coli, stressed cells
have evolved mechanisms to license the increase of error‐prone repair at genetic regions
surrounding DNA double‐stranded breaks [4], which occur at a 10−3 frequency spontaneously
[5]. Repair of double‐stranded breaks, processed by recombination, can generate point mutations
produced via error‐prone synthesis or genetic amplifications that confer fitness to cells
experiencing limited replication [6–8]. Interestingly, genetic regions undergoing transcription in
stressed cells can precipitate the formation of double‐stranded breaks via the formation of R‐
loops [9]. Also, factors affecting transcription termination influence stress‐induced mutagenesis
[10]. Therefore, the observations above support a model in which stressed E. coli manage
increases in genetic diversity by activating mechanisms that operate on a subpopulation of cells
and transcribed DNA undergoing repair of double‐stranded breaks [1].
In the context of increasing genetic diversity in times of nutritional stress, B. subtilis halts
replication and differentiates subpopulations [11,12]. One subpopulation of cells become
naturally competent, a strategy to acquire new genes from the environment by the process of
recombination [13]. Interestingly, Bacillus subtilis also expresses stationary‐phase mutagenesis.
In these processes, the transcription repair coupling factor Mfd plays a central role, interacting
with components of the nucleotide excision repair (NER) or base excision repair (BER)
pathways and error‐prone polymerases to produce mutations in stationary‐phase cells [14]. This
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type of mutation occurs under endogenous levels of DNA damage or when cells are exposed to
oxidants that inflict DNA lesions. These observations support a mutagenic model in which
actively transcribed genes accumulate more mutations than those that are repressed through
error‐prone repair. However, whether other post-exponential processes, including the
development of a competent subpopulation, contributes to stationary‐phase mutagenesis remains
an open question.
Sung and Yasbin contributed two interesting observations to our understanding of
stationary-phase mutagenesis [2]. RecA, and therefore the process of genetic recombination, is
not required for this process. Also, inactivation of ComK, a transcriptional regulator that controls
the late steps in the development of the competence subpopulation, decreased stationary‐phase
reversions to methionine prototrophy. Moreover, the inactivation of ComA, which controls the
early steps in competence development, did not affect Met+ reversions [2]. These observations
suggest that the genetic changes producing Met+ reversions in stationary‐phase B. subtilis are
promoted by the late steps that differentiate cells into competence in the absence of genetic
recombination.
Characterization of the formation of the competent subpopulation has redefined this cell
differentiation pathway as a mechanism to cope with stress that goes beyond promoting genetic
recombination [15]. Transcriptomics studying the K‐state (the competent state) show that
recombination genes are only a subset of genes activated during competence. K‐cells also
express factors that detoxify cells, facilitate uptake and use of nutrients, and repair DNA lesions
[15]. Given these observations, we examined the idea that the development of the K‐state leads
to conditions that predispose cells to accumulate stationary‐phase mutations even in the absence
of DNA uptake that provides the substrate for genetic recombination.
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Our experiments showed that cells that undergo genetic transformation are more likely to
become stationary‐phase mutants and that oxidative damage to DNA is a precursor to the
formation of mutations. Furthermore, stationary‐phase Met+ mutagenesis occurs in K‐cells that
are deficient in the uptake of DNA, but at slightly lower levels than in cells containing a
functional uptake apparatus (ComEA+ cells). To better study this phenomenon, we used a
ComK‐inducible system to turn all the cells in the culture into the K‐state and measure
mutagenesis. We found that ComEA‐ cells produced fewer stationary‐phase mutants than their
ComEA+ counterparts but tolerated oxidant exposure better than ComEA+ cells. Furthermore, K‐
cells showed better survival to oxidative stress than non‐K‐cells, which indicated that this
differentiation state activates mechanisms that repair oxidative damage. We followed these
observations with microscopy assays of K‐cells differing in ComEA and measured fluorescence
of an indicator dye as a proxy for oxidative damage. These assays showed that, under oxidative
stress, ComEA‐ cells were less damaged than ComEA+ cells. These results support the concept
that developing into the K‐state, which includes installing a functional DNA uptake system in the
cell surface, predisposes B. subtilis to oxidative damage. K‐cells activate mechanisms to survive
oxidative damage and increase mutagenesis in cells under non‐lethal selection pressure.
Therefore, B. subtilis K‐cells increase genetic diversity via recombination-dependent and
recombination‐independent pathways.

Materials and Methods
Bacterial Strains and Growth Conditions
B. subtilis strains used in this study are all derivatives of the strain YB955 and are
described in Table 4.1. YB955 is a prophage‐cured 168 strain that contains the following
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auxotrophic genes: hisC952, metB5, and leuC427 [2]. B. subtilis strains were all maintained on
tryptose blood agar base medium (TBAB; Difco Laboratories, Sparks, MD, USA) or grown in
liquid cultures in Penassay broth (PAB) (antibiotic A3 medium; Difco Laboratories, Sparks, MD,
USA) with antibiotics, such as 5 μg/mL of neomycin (Nm), 100 μg/mL of spectinomycin (Sp), 5
μg/mL chloramphenicol (Cm), or 10 μg/mL of tetracycline (Tc), as needed. Escherichia coli
strains were maintained and grown on Luria–Bertani (LB) with antibiotics as needed.
The strain containing a defective comEA gene (JC101) was constructed by cloning a
neomycin cassette within the comEA gene. Two sets of primers (see Table 4.2) were designed to
amplify regions of comEA from YB955. The primers were flanked with restriction sites
compatible with plasmid pBest502 [19]. The fragments were digested with the appropriate
restriction enzyme sites and ligated to pBest502. The ligation product was transformed into E.
coli Mon1 competent cells according to the manufacturer’s recommendations (Monserate, San
Diego, CA, USA). Transformants were selected on ampicillin and screened by restriction
enzyme analysis. This plasmid was transformed into YB955, as previously described [20].
Briefly, B. subtilis YB955 was grown to T90, ninety minutes after the cessation of growth
(stationary phase), in GM1 broth (0.5% dextrose, 0.1% yeast extract, 0.2% casein hydrolysate,
essential amino acids 50 μg ml−1, 1X Spizizen salt solution [21] and then diluted 10‐fold into
GM2 broth (GM1 broth plus 50 μM CaCl2, 250 μM MgCl2). After one hour of incubation at 37
°C with aeration, plasmid DNA (100 ng) was added. The culture was incubated for another hour,
followed by the addition of 100 μL of 10% yeast extract. After an additional hour of incubation,
the cells were plated on TBAB containing 5 μg/mL neomycin to select for the comEA::neoR
allele. Then comEA‐ transformants were screened by PCR.
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To construct the comK‐gfp IPTG‐inducible strain, genomic DNA was isolated from B.
subtilis BD401021 using the Wizard® Genomic DNA Purification Kit (Promega, Madison, WI,
USA). Isolated genomic DNA was then transformed into YB955 using the competence
procedures for B. subtilis described above [20]. Cells were plated on TBAB containing 100
μg/mL spectinomycin to select for the amyE::pHS‐comK allele and 5 μg/mL chloramphenicol to
select for the comK‐gfp allele. Transformants were verified by flow cytometry using IPTG and
comparing the fluorescence intensity of induced versus uninduced cells in relation to parental
cells (YB955).
To construct the gfp‐comK IPTG‐inducible comEA knockout strain, genomic DNA from
JC101 was extracted using Wizard® Genomic DNA Purification Kit (Promega, Madison, WI,
USA). The genomic DNA was then transformed into HAM501 using the competence protocol
described above. Cells were plated on TBAB containing 100 μg/mL spectinomycin, 5 μg/mL
chloramphenicol, and 5 μg/mL neomycin. Transformants were verified using the transformation
assay described above and transformed using the plasmid pDG1664 [18] containing
erythromycin resistance. The inability to be transformed was used to confirm the desired
genotype.

Stationary-Phase Mutagenesis Assay
As previously described [2], one colony of each strain was used to inoculate two mL of
PAB. This was grown overnight in a shaking incubator at 37 °C with aeration (250 rpm). The
next day, 1 mL of the overnight culture was transferred into 20 mL of PAB with 20 μL of 1000×
Ho‐Le trace elements into a 250‐mL Erlenmeyer flask. Growth was monitored with a Genesys
10S UV–vis (Thermo Scientific, Waltham, MA, USA) until T90. Cells were then harvested by
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centrifugation at room temperature and resuspended in 1× Spizizen minimal salts. Cells were
then plated in quintuplet (100 μL per plate) on 1× Spizizen minimal medium (SMM; 1× Spizizen
salts supplemented with 0.5% glucose, 50 μg/mL of both isoleucine and glutamic acid and either
50 μg/mL or 200 ng/mL of methionine, histidine, and leucine. The lower concentration of amino
acid was used to select for revertants. These plates were incubated for nine days with revertants
scored every day. To determine the initial number of cells plated, the cell suspension was serial
diluted by 6 log10 units and plated onto SMM containing 50 μg/mL of each required amino
acids. The experiments were repeated at least three times.
To determine the viability of the non‐revertant background cells, agar plugs were
removed from each minimal plate using Pasteur pipettes every other day. These plugs were taken
from areas of the plate that contained no visible colonies. The plugs were resuspended in 0.5 mL
of 1× SMS solution, then serially diluted by 4 log units, and plated on SMM containing all the
essential amino acids. These plates were incubated at 37 °C for two days before being colonies
were counted.

Oxidative-Stress Induced Stationary-Phase Mutagenesis Assay
To determine the effects of oxidative stress on B. subtilis, cells were grown as described
in the stationary‐phase mutagenesis assay with the following differences. When using the
ComK‐inducible strains, cells were propagated to an OD600 of 0.75; at this point, the cultures
were divided in half and one portion was induced with 1 mM IPTG. When both cultures reached
T90 (90 minutes after the cessation of growth), they were treated with 0 or 1.5 mM tert‐butyl
hydroperoxide (t‐BHP; Luperox(R) Sigma‐Aldrich, St. Louis, MO, USA) for two hours, washed
with 1X SMS twice, then plated, and assayed for stationary‐phase mutagenesis.
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Transformation Stationary-Phase Mutagenesis Assay
Strains were grown overnight in GM1 with Ho‐Le trace elements in a 250 mL
Erlenmeyer flask on a bench top at room temperature for approximately 16 hours. The next day,
the culture was incubated in a shaker at 37 °C with aeration (250 rpm). Growth was monitored
with a Genesys 10S UV–vis (Thermo Scientific, Waltham, MA, USA) until T90. The culture was
then diluted 10‐fold into GM2 and incubated for one hour as previously described. Finally, the
culture was split into two different batches. Then, 150 ng of the transforming DNA (pDR111; a
gift from Dr. David Rudner) was added to one subset of the culture, while nothing was added to
the other subset of the culture, which served as the no‐DNA control. In addition, a broth‐only
control was used.
Cells were incubated for an additional hour, followed by the addition of 10% yeast
extract to all three subsets. Cells were incubated one final hour and subsequently harvested. Cells
were harvested by centrifugation at room temperature and resuspended in 1× SMS. Cells from
the DNA treatment and no DNA cultures were plated in quintuplet (100 μL per plate) on both
SMM and TBAB with 100 ng/mL of spectinomycin, which assessed transformation efficiency
and spontaneous spectinomycin reversion. The SMM plates were incubated for 9 days with
revertants scored every day. To determine the initial number of cells plated, the beginning cell
suspension was serially diluted by 6 log10 units and plated onto medium containing all the
required amino acids. The experiments were repeated at least three times. The viability of the
cells of the non‐revertant background cells was assessed as described above.
To determine if prototrophic revertants were also transformants, colonies were screened
for growth on TBAB with 100 ng/mL of spectinomycin. As a control, non‐revertant colonies
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(colonies that arose from plugs that were grown onto minimal plates containing all essential
amino acids) were subject to the same screening.

Flow Cytometry
B. subtilis strains, HAM501 and AAK502, were grown to mid‐exponential phase and T90.
A batch of cells were divided into two sets at a late exponential phase (0.7–0.8 OD600) and
IPTG was added to one set. Then, both sets (with and without IPTG) were grown until T90
(stationary phase). A 1‐mL aliquot from each condition was removed at a late exponential phase,
as well as the stationary phase, and combined with 50 μL of 37% formaldehyde. This mixture
was centrifuged for 10 min at 300× g (2100 rpm) in a microcentrifuge tube. The supernatant was
decanted, and the pellet was resuspended in 1 mL of phosphate‐buffered saline (PBS). Samples
were covered in foil until they were run through the BD FACSCalibur flow cytometer.

Fluorescence Microscopy
One colony of each strain was used to inoculate 2 mL of PAB. This culture was grown
overnight in a shaking incubator at 37 °C with aeration (250 rpm). One milliliter of the overnight
culture was transferred into 20 mL of PAB with 20 μL of 1000× Ho‐Le trace elements into 250
mL Erlenmeyer flask. Growth was monitored with a Genesys 10S UV–vis (Thermo Scientific,
Waltham, MA, USA) until OD600 of approximately 0.75. Then cultures were divided into halves,
and one half was induced with 1 mM IPTG. We monitored the growth of the cultures until the
transition from exponential to stationary phase was identified (typically around an OD600 of
1.5). At T50 (50 minutes after the cessation of growth), each condition was pre‐labeled by adding
5 μM peroxy‐orange 1 (PO1, Tocris, Bristol, UK). PO1 measures the concentration of H2O2
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since PO1 only becomes fluorescent after oxidation by H2O2 which removes a protective
boronate side group [22]. Therefore, we can assay the ROS levels of a cell by pre‐loading cells
with PO1 and subsequently exposing them to an oxidant like t‐BHP. This technique has been
used to measure ROS in different cell types [22,23]. Cultures were returned to the incubator and
grown to T90. At this point, each condition was divided and exposed to either 0 or 5 mM of t‐
BHP for 2 hours. Cells were then harvested by centrifugation, washed twice with 1X SMS, and
serially diluted.
To determine percent survival, we plated 0.1 mL of serial 10‐fold dilutions onto TBAB,
incubated the plates for 24 hours at 37 °C, and scored for colonies to determine survival. Percent
survival was determined by dividing the number of CFUs from the exposed conditions by the
number of CFUs from the 0 mM condition. We repeated this procedure at least three times, with
three replicates each time.
To visualize the amount of ROS in the cell, 0.8 μL of a 10−1 diluted culture was
immobilized in a 1% agarose pad on a clean glass slide before imaging. Live cell imaging was
conducted using transmitted light and fluorescence microscopy (Zeiss Axio Upright Imager M2,
Oberkochen, Germany) equipped with oil immersion (Plan‐Apochromat 63×/1.40 Oil Ph3 M27).
Fluorescence excitation was performed (X‐cite 120LED) at a range of 550–605 nm (43 HE
dsRed Zeiss Filter). Images were captured by an ORCA Flash 4.0 LT Monochromatic Digital
CMOS camera. Image analysis was completed using MicrobeJ. Fluorescent foci were detected
and counted using the maxima feature in MicrobeJ. Maxima are considered the regions of
highest fluorescence within a cell. We used this measurement to quantify the amount of oxidized
PO1 molecules within cells. Cell length was measured using the medial axis feature in MicrobeJ
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[24]. At least six fields of view were captured for each strain and condition tested, thus resulting
in the imaging of several hundred cells for all conditions.

Statistical Analysis
We used SPSS 24 software for data processing and analysis. To test whether the
proportion of stationary‐phase revertants that underwent transformation was different from the
proportion of non-revertants that underwent transformation, we conducted a chi2 test. For the
chi‐square analysis, we first standardized the number of SpcR colonies for each population to the
non‐revertant cells that were transformed with DNA (n = 1755). Then, we constructed a
contingency table to test the independence between the two conditions of transformation (DNA
added and No DNA) and the population type (non‐revertant, early revertant, and late revertant)
and found that these variables were independent (chi‐square value 5.04, d.f. 2). Then, we tested
the number of transformants in each population type for each condition of transformation
separately. In the DNA added condition, we used the number of transformants in the non‐
revertant population as the expected value; the number of transformants in each of the revertant
populations (early and late revertants) was considered the observed value. The chi‐square value
for the DNA added condition was 208 (d.f. 1), which indicated a significant difference between
the non‐revertant and revertant populations. The same analysis was repeated in the No DNA
added condition and the chi‐square value was 3.6 (d.f. 1), which indicated no significant
differences among the three populations. The results are presented in percent in Table 4.3.
For the rest of the experiments, statistical significance was determined by performing
ANOVA. Significance was tested at p < 0.05. Means were tested using the LSD test at p < 0.05.
The data from experiments in which cells were untreated or treated with t‐BHP was LOG
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transformed to normalize distributions and analyzed by ANOVA. We used a letter system to
denote significant differences between means. We assigned “a” to the means that were not
significantly different from the mean with the highest value, “b” to means that were different
from the “a” group, and so on.

Results
Stationary-Phase Revertants Are More Likely to Be K-Cells than the Background Population
To investigate the relationship between the K‐state and stationary‐phase mutagenesis, we
revisited the observations by Sung and Yasbin [2]. They examined the accumulation of
mutations in three amino acid biosynthesis genes in stationary‐phase cells under nutritional stress
over a period of nine days. They conducted these assays in different genetic backgrounds,
including recA and the general stress sigma factor σB (σS in E. coli). These genes encode key
factors (RecA) or activate genes important in stress‐induced mutagenesis in E. coli [1]. Those
experiments also included the ComA and ComK factors which control the development of
competence, a state in which cells incorporate foreign DNA into the chromosome via
homologous recombination [2]. Moreover, the inactivation of ComK, which controls the late
steps in the formation of the K‐state, resulted in a marked decrease of Met+ reversions, but the
inactivation of ComA, which controls the early steps, did not [2,25]. These observations
suggested that the genetic changes producing Met+ reversions in stationary‐phase B. subtilis are
promoted by the late steps that differentiate cells into competence in the absence of genetic
recombination. Experimentally, we modified our stationary‐phase mutagenesis assay to measure
the contribution of the development of the K‐state among revertants. Briefly, cells of the strain
YB955, which is auxotrophic for methionine, were grown to T90 (ninety minutes passed the
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cessation of exponential phase) and prepped for transformation. Then, the plasmid, pDR111,
which contains a selectable spectinomycin cassette, was supplied to half of the cells. The
spectinomycin cassette is not linked to any of the methionine auxotrophy. The other half of the
cells underwent the same preparation but were not exposed to the plasmid. Instead of selecting
for the transformation of the plasmid, we plated the cell preparations to select for Met+
stationary‐phase colonies. We tracked revertant colonies for nine days but considered only those
colonies that arose on day 5 or later to be stationary‐phase mutants (Fig. 4.1). Previous
experiments that established the system to measure stationary‐phase mutagenesis in B. subtilis
characterized mutants at different times of incubation on selective media and conducted
reconstruction experiments. Based on the genetic changes and the growth ability of late
revertants in the presence of non‐revertants, those reports showed that colonies that arise in the
first 3–4 days after the onset of selection are the product of growth‐dependent processes
[2,26,27]. Then we used day 5 to differentiate revertants as early or late. During this time, the
non‐revertant background population was measured for its ability to survive (Fig. 4.1) (see
Methods). Those results showed a constant level of CFU throughout nine days.
To determine if the K‐state correlated with stationary‐phase mutagenesis, both revertant
colonies and non‐revertant colonies were screened for growth on tryptose blood agar base
(TBAB) containing 100 μg/mL spectinomycin, which selects for transformants (Table 4.3).
When we conducted the transformation procedure with the plasmid, we found that 10.9% of
early revertants, colonies that arose between days 1 and 4, and 18.1% of late revertants, colonies
that arose after day 5, were resistant to spectinomycin. In contrast, only 1.7% of the non‐
revertant colonies were resistant to spectinomycin. B. subtilis cells can become resistant to
spectinomycin through a spontaneous single base‐pair mutation [28]. To estimate the proportion
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of colonies that arose through spectinomycin-resistant spontaneous mutations and not through
the uptake of the plasmid during the transformation, we patched early revertants, late revertants,
and non‐revertants that were not exposed to pDR111 during the transformation procedure. We
found that when no plasmid DNA was added, 4.0%, 1.0%, and 1.6% of early revertants, late
revertants, and non‐revertants, respectively, were resistant to spectinomycin (Table 4.3). The chi‐
square test results suggest that a majority of the spectinomycin‐resistant revertants from the
DNA‐added condition were due to the development of competence and the uptake of plasmid
DNA. These observations are congruent with the finding that the development of the K‐state
promoted stationary‐phase mutagenesis.

Stationary-Phase Mutagenesis Occurs Independently of DNA Uptake
To follow up on the previous result (Table 4.3) and the observations by Sung and Yasbin
[2], we tested whether the development of the K‐state promoted stationary‐phase mutagenesis
independently of DNA uptake. We constructed JC101, with a neomycin gene interrupting the
comEA gene, and measured stationary‐phase Met+ mutagenesis. The ComEA protein is a
component of the competence pore that binds and uptakes DNA during the transformation of B.
subtilis [29]. The competence pore is a complex of proteins that mediates the binding,
translocating, single‐stranded forming, and the recombining of foreign DNA into the
chromosome. ComEA binds and transports DNA into competent cells during DNA
transformation [29]. Cells lacking ComEA are essentially untransformable [29]. We found the
ComEA‐ strain is transformation‐defective, as previously reported (Table 4.4). Then, we assayed
JC101 and YB955 for their ability to produce stationary‐phase revertants and found no
significant difference between these two strains (Fig. 4.2A). In addition, there were no
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differences between the viability of the non‐revertant background populations throughout the
experiment (Fig. 4.3). Further, we conducted the stationary-phase mutagenesis assay in the
presence of genomic DNA extracted from a YB955 background defective in MutY, a DNA
glycosylase that repairs DNA mismatches caused by oxidative damage [30]. Cells lacking MutY
have higher mutation rates when exposed to oxidants than parental strains [31]. The DNA donor
cells were either treated with t‐BHP or untreated. The results of those experiments revealed no
differences in stationary‐phase mutagenesis (Fig. 4.2B). Also, the levels of stationary‐phase
mutagenesis were like those observed in the absence of DNA. These results agree with previous
findings that suggest the development of the K‐state, and not recombination nor transformation
(nor the transport of oxidized DNA bases), are important in the development of stationary‐phase
mutants.

Oxidative Stress Potentiates Mutagenesis in K-Cells
The K‐state in B. subtilis is a bi‐stable system, and only ~15% of the cells in a culture
develop into this state [32]. To test further whether the K‐state promotes stationary‐phase
mutagenesis, we constructed a YB955 genetic background with an IPTG‐inducible comK system
[16]; this strain was named HAM501. We introduced the comEA‐ mutation into HAM501, which
originated AAK502. This system induces all cells in a culture to develop into the K‐state when
IPTG is supplied exogenously. These strains contain a copy of comK under the control of IPTG
and express gfp under the control of a ComK promoter, which allows for the visual examination
of cells undergoing the development of the K‐state. We tested the transformation ability of both
strains and observed that AAK502 was not transformable even in the presence of damaged DNA
(Table 4.5).
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To determine if cells lacking ComEA were affected in the expression of the ComK
regulon, we grew cultures to an OD600 of 0.75 and split them in half. One half was induced with
1 mM IPTG while the other half was not. Cells continued to grow until T90, when they were
harvested. Induction of the ComK regulon was measured using flow cytometry to assay the
amount and intensity of cells expressing GFP under these conditions (Fig. 4.4). Both HAM501
and AAK502, ComEA‐, showed a dramatic and equivalent increase in GFP fluorescence in cells
induced with IPTG compared to uninduced cells. This result suggests that the interruption of
comEA does not affect the activity of ComK‐regulated genes and rules out the possibility that
defects in ComEA have downstream effects on stationary‐phase mutagenesis.
Recent work has demonstrated the importance of reactive oxygen species (ROS) in the
generation of stationary‐phase mutations [31]. Interestingly, PerR, a transcription factor activated
in response to increases in ROS stabilizes ComK levels in the cell [33]. This prompted us to
investigate the roles of ROS in combination with the development of the K‐state in the formation
of stationary-phase revertants. Therefore, we modified our traditional stationary‐phase
mutagenesis assay to include exposure to the oxidant, t‐BHP, and transcriptional induction of the
comK gene. Briefly, HAM501 and AAK502 (ComEA‐) cells were grown to T90, induced into the
K‐state by supplying IPTG, exposed to 0‐ or 1.5‐mM t‐BHP for two hours, washed twice, and
plated on minimal medium lacking methionine. The results over the nine days are presented in
Figure 4.5. Fig. 4.6A presents the number of revertants from days 5 thru 9, which shows, as
expected, that the number of revertants was increased when both strains were exposed to t‐BHP.
However, in the absence of t‐BHP treatment, cells lacking ComEA accumulated fewer mutants
than ComEA+ cells. Strikingly, when K‐cells were damaged with t‐BHP, ComEA+ cells
accumulated significantly more mutations than those that lack ComEA (Fig. 4.6A). The
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background non‐revertant population was measured for its viability (Fig. 4.5), and those data
suggest that long‐term survival of the strains in selective media is unaffected between strains.
Furthermore, the ability of AAK502 (ComEA‐) to revert to the revertant levels of HAM501
(ComEA+) in conditions in which cells were not treated with t‐BHP (Fig. 4.6A) indicates that
stationary‐phase mutagenesis is independent of DNA uptake. These results suggest that K‐cells
can engage in a pro‐mutagenic process triggered by oxidative damage and that the presence of a
functional DNA uptake system increases oxidative damage and the pro‐mutagenic process.
To test whether the observed increased stationary‐phase mutagenesis levels in K‐cells are
associated with increased tolerance to and repair of cellular damage caused by ROS, we
conducted cell survival and microscopy assays in untreated cells or cells exposed to t‐BHP and
in conditions in which cultures were non‐induced or induced into the K‐state (addition of IPTG).
Survival assays indicated that tolerance to oxidative damage was increased in K‐cells compared
to non‐K‐cells (Fig. 4.7). Within the K‐cell population, ComEA‐ cells survived oxidant exposure
better than ComEA+ cells, with the former cells surviving at an average of 36.4% and the later
cells surviving at an average of 28.2%. Interestingly, when treated with t‐BHP, ComEA‐ cells
showed significantly fewer maxima than their ComEA+ counterparts (Fig. 4.6C). Even so,
ComEA‐ cells showed less fluorescence than ComEA+ cells, albeit not significantly (Fig. 4.6B).
Altogether, these results suggest that the development of the K‐state, which includes modifying
the cell surface for the uptake of DNA, activates a mechanism that protects against the noxious
effects inflicted by oxidants, which includes DNA lesions. One associated consequence of the
activation of this mechanism is an increase in mutagenesis in cells under selection.
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Discussion
Previous work has demonstrated that ComK is important for the accumulation of
mutations during stress conditions in B. subtilis [2]. However, unlike in Escherichia coli, this
process is independent of recombination [1,2]. Historically, the development of competence was
synonymous with genetic transformation. Yet, findings by Berka et al. showed that the K‐state
was more dynamic than simply a precursor to transformation [15]. These disparate observations
prompted us to investigate how the K‐state promotes stationary‐phase mutagenesis in the
absence of genetic recombination [2]. Stationary‐phase mutagenesis mechanisms provide
insights into evolution and can explain how bacterial cells develop genetic adaptation to escape
from host defenses and antibiotic treatment.
First, our experiments showed that the population of stationary‐phase revertants had a
higher proportion of transforming DNA than the non‐revertants from experiments that examined
mutations in different genes (Table 4.3, Fig. 4.1). We interpreted this result to indicate that the
changes associated with the development of the K‐state were conducive to stationary‐phase
mutagenesis. Gene expression and genetic studies demonstrated that the competence state
activates genes that respond to DNA damage, most notably the SOS system, DNA uptake and
recombination pathways, and oxidative stress [34,35]. Previous experiments showed that the
RecA protein was not involved in stationary‐phase mutagenesis, which led us to further study
how the K‐pathway influences stationary‐phase mutagenesis.
Next, we tested the possibility that the uptake of exogenous DNA, another trademark
characteristic of the K‐state, influences stationary‐phase mutagenesis. However, the DNA‐uptake
defective strain showed no significant differences in stationary‐phase mutagenesis levels when
compared to its wild‐type counterpart. This result suggested that the process of DNA binding and
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uptake are dispensable to the formation of stationary‐phase revertants (Fig. 4.2). Interestingly,
we noted that the non‐transformable ComEA‐ strain accumulated slightly less revertants than the
wild type. Perhaps, the modification of the cell surface (assembly of a functional DNA uptake
system) predisposes the cell to cytotoxic and genotoxic damage, which in turn activates a
protective, error-prone DNA repair response that produces mutations. Interestingly, studies that
examine protein networks and endogenous DNA damage revealed that increases in reactive
oxygen species are associated with the presence of transmembrane transporters in E. coli [36].
Further, reports examining K‐cells in B. subtilis showed activation of detoxication mechanisms
[15,34].
To test the idea that the presence of a functional DNA uptake system increases oxidative
damage in cells and consequently stationary‐phase mutagenesis, we tested cultures induced to
develop into the K‐state for their ability to generate stationary‐phase mutants in the absence and
presence of ComEA, and as affected by exposure to the oxidant tert‐butyl hydroperoxide. The
results indicated the following. (1) In the absence of ComEA and t‐BHP treatment, K‐cells still
produced stationary-phase mutants. (2) ComEA+ cells accumulated more mutants than cells
lacking this protein. (3) When cells were exposed to an oxidant, the same response pattern was
observed in stationary‐phase mutagenesis (Fig. 4.6A). Also, we quantified cell survival and cell
damage via florescence after exposure to t‐BHP. Our results showed that induction of the K‐state
resulted in increased cell survival to oxidant exposure (Fig. 4.7). One likely explanation for this
outcome is that K‐cells activate genes that detoxify compounds [15]. However, one interesting
finding was that ComEA+ cells displayed a lower cell survival than ComEA‐ cells, which
suggested that the presence of a functional DNA uptake system predisposes cells to oxidative
damage.
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We visualized cells after exposure to t‐BHP by using a fluorescent probe that responds to
oxidative damage. The average maxima were significantly higher in ComEA+ cells than in
ComEA- cells after exposure to t‐BHP, (Fig. 4.6C). These results suggest that producing a
functional DNA uptake apparatus compromises the cell’s ability to withstand oxidative damage.
Altogether, we conclude that the activation of the K‐state leads to the alteration of the cell
surface and that such changes predispose the cell to accumulate oxidative damage, as measured
by fluorescent maxima in t‐BHP treated cells (Fig. 4.6C). This notion is supported by reports that
showed overlap between the regulons activated in the K‐cell state and cells experiencing
oxidative or cell envelope stress [15,37,38]. The increase in oxidative damage is followed by
activation of mechanisms that actively repair DNA lesions [15]. This assertion is supported by
the increased survival to the oxidant observed in the K population of cells (Fig. 4.7). We
speculate that the DNA repair reactions activated in K‐cells occur via error‐prone repair as
attested by the increased stationary‐phase mutagenesis levels in such cells (Fig. 4.6A). This
stationary‐phase mutagenic process is independent of the process of genetic transformation,
which suggests that the K‐state increases genetic diversity via Rec‐dependent and Rec‐
independent pathways.
The observations presented here, in combination with research that showed that highly
transcribed genes accumulate mutations in cells under oxidative stress [31], supports a concept in
which stressed B. subtilis cells limit increased mutagenesis to a fraction of cells and to genomic
regions under elevated transcriptional activity. This strategy increases the potential to gain
fitness and minimizes risks in B. subtilis, quintessentially known to adapt to stress via the
development of different subpopulations [39]. E. coli employs a different strategy to mitigate the
risks associated with increases of genetic diversity; mutagenic break repair happens in regions
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suffering double‐stranded breaks [40]. Spontaneous double‐strand breaks happen in a fraction of
the cell population and the likelihood of it occurring is increased in transcribed regions [5,9].
This is supported by reports that demonstrated factors influencing transcription termination
affected stress‐induced mutagenesis in E. coli [10,41]. Interestingly, oxidative damage to DNA
has been implicated in stress‐induced and stationary‐phase mutagenesis in both bacterial models,
but the pathways that process this damage and produce mutations are not evolutionarily
conserved. Therefore, minimizing the risks associated with increased mutagenesis in stressed
cells exemplifies convergent evolution [7]. These findings support a scenario in which cells can
regulate the ability to evolve (reviewed in [7]) and provide insights in the formation of mutations
that, in bacterial pathogens, can lead to the formation of antibiotic resistance [42] and increased
fitness that prolong chronic infections [43].
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Figures & Tables
Table 4.1. Strains and plasmids used in this study.
Strain Name

Genotype

Reference or Source

hisC952 metB5 leuC427 xin-1 Spβ SENS

[2]

YB955 comEA::neo

This study

Bacillus subtilis
strains
YB955
JC101

YB955 amyE::Phs—comK (sp) comK-gfp (CBL,
HAM501

This study
cm)

HAM502

HAM501 hom::erm

This study

AAK502

HAM501 comEA::neo

This study

his leu met amyE:: Phs–comK (spc) comK-gfp
BD4010

[19]
(cat)

Escherichia coli
strain
endA1 recA1 mcrA ∆(mrr-hsdRMS-mcrBC)

Monserate

Ф80lacZ∆M15∆lacX74 ∆(ara,leu7697 ara ∆139

Biotechnology Group

galU galK nupG rpsL F- λ-

(San Diego, CA)

pDR111

Integrative plasmid, confers SpR

David Rudner

pBEST502

Integrative plasmid, confers NmR

[16]

pDG1664

Integrative plasmid, confers MLSR

[17]

Mon1

Plasmids
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Table 4.2. Primers used in this study.
Primer Name Primer Sequence

1

comEA A fwd

agctggaagctttaaggtaacgctcttgccag

comEA A rvs

agccgtgtcgacaaatttacttgcgcttcgtc

comEA B fwd

agtcacggatcctctgcaggacgggacagtgg

comEA B rvs

aagcctcgagctctccatcagtcggcaccccaaac

Underlined sequences correspond to restriction sites.
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Figure 4.1. The accumulation of stationary-phase mutations under conditions of amino acid
starvation in YB955 (parental strain) after addition of a transformation marker pDR111. (A) The
trend of the accumulation of revertants is constant with previous SPM experiments. (B) The nonrevertant background remains constant throughout the 9 days. Data represents the average of
three separate tests ± standard error of the mean (SEM).
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Table 4.3. Percentage of stationary-phase revertants that were resistant to spectinomycin.
Early Revertants Late Revertants
Condition

Non-Revertants
(From Days 1–4)

(From Days 5–9)

10.9% *

18.1% *

1.7%

n = 550

n = 545

n = 1755

4.0%

1.0%

1.6%

n = 100

n = 100

n = 440

DNA added

No DNA added

* Denotes chi-square test of p < 0.05. See the statistical analysis section for more details.
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Table 4.4. Number of colonies resistant to spectinomycin following transformation with
pDR111 in wild-type (YB955) and cells lacking ComEA (JC101).
Strain &

High DNA

Low DNA (1

Replicate

(10 ng)

ng)

Cells Only

DNA Only

Titres (10-7)

YB955 1

296

35

0

0

61, 65, 76

YB955 2

68

19

0

0

78, 72, 76

YB955 3

147

16

0

0

54, 63, 58

YB955 4

223

63

0

0

95, 88, 60

YB955 5

288

64

0

0

76, 64, 77

YB955 6

382

56

0

0

66, 65, 58

YB955 7

344

94

5

0

74, 75, 90

YB955 8

254

63

4

0

66, 56, 67

YB955 9

190

91

0

0

48, 65, 62

YB955 10

175

46

0

0

61, 56, 63

YB955 11

178

21

0

0

87, 100, 163

YB955 12

115

24

0

0

159, 92, 78

JC101 1

1

0

0

0

78, 78, 87

JC101 2

0

5

0

0

84, 82, 83

JC101 3

0

0

4

0

95, 83, 115

JC101 4

0

0

1

0

87, 107, 104

JC101 5

0

1

0

0

75, 83, 73

JC101 6

4

0

0

0

76, 95, 83

JC101 7

0

0

0

0

80, 72, 81

115

JC101 8

0

2

0

0

104, 125, 137

JC101 9

0

0

0

0

65, 75, 94

JC101 10

1

6

0

0

95, 86, 114

JC101 11

0

0

0

0

71, 89, 83

JC101 12

0

0

0

0

72, 70, 67
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Figure 4.2. Stationary-phase mutagenesis is DNA-uptake independent. (A) The accumulation of
stationary-phase Met+ revertants under conditions of amino acid starvation in YB955 (parental
strain) and JC101 (comEA-). Student’s t-test conducted. (B) The accumulation of stationaryphase Met+ revertants under conditions of amino acid starvation in YB955 after being supplied
with DNA that was not treated (NT) or treated with tert-butyl hydroperoxide (TBH) before the
DNA was isolated. Data represent the average of at least three separate tests ± standard error of
the mean (SEM); ns denotes no significant differences between strains.
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A

1.00E+06

Revertants/107 CFU

1.00E+05
1.00E+04
1.00E+03
Wild-type
1.00E+02

ComEA-

1.00E+01
1.00E+00
1

3

5

7

9

Days After Plating

B

Figure 4.3. Non-revertant background viability from Fig. 4.2. A) Viability of the wild-type
(YB955) and ComEA-deficient cells over the nine-day stationary-phase mutagenesis assay. B)
Viability of YB955 cells supplied with either DNA from a MutY-deficient strain treated with
either 0- or 1.5-mM t-BHP for two hours before the DNA was isolated. Each point represents an
average of five samples.
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Table 4.5. Number of colonies resistant to erythromycin following transformation into HAM501
(ComEA+) or AAK502 (ComEA-) with DNA from HAM502 (HAM501 hom::erm) cells that
were treated with 10 mM of t-BHP for two hours before the DNA was isolated.

Strain &
Transformants

Cells Only

DNA Only

Titres (10-7)

HAM501 1

31, 21

0

0

50, 73

HAM501 2

1, 1

0

0

94, 127

HAM501 3

10, 14

1

0

81, 60

HAM501 4

20, 26

4

0

51, 41

AAK502 1

0, 0

0

0

51, 51

AAK502 2

0, 0

0

0

35, 38

AAK502 3

0, 0

0

5

49, 61

AAK502 4

0, 0

0

4

34, 60

Replicate
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Figure 4.4. The fluorescence intensity of cells following induction measured by flow cytometry.
The top panel of A shows the uninduced wild-type cells (HAM501), whereas the bottom panel of
A shows the uninduced cells lacking ComEA (AAK502). The top panel of B shows the induced
wild-type cells (HAM501), whereas the bottom panel of B shows the induced cells lacking
ComEA (AAK502).
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Figure 4.5. A) Accumulation of Met+ revertants over nine days in the wild-type (HAM501) and
the ComEA- mutant (AAK502). All conditions were induced with IPTG (i) and half were
exposed to 1.5 mM t-BHP for two hours. B) Viability of the wild-type (HAM501) and ComEAdeficient (AAK502) cells either treated with 0- or 1.5-mM t-BHP over the nine-day stationaryphase mutagenesis assay.
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Figure 4.6. Stationary-phase mutagenesis and fluorescent microscopy with PO1. (A) The
accumulation of stationary-phase revertants from days 5–9 in K-cells (HAM501) or K-cells
lacking ComEA (AAK502) following treatment with either 0- or 1.5-mM t-BHP for two hours.
(B) The average fluorescence within either induced or uninduced wild-type cells (HAM501) or
cells lacking ComEA (AAK502) following treatment with either 0- or 5-mM t-BHP for two
hours. (C) The average number of PO1 maxima within either induced or uninduced wild-type
cells (HAM501) or cells lacking ComEA (AAK502) following treatment with either 0- or 5-mM
t-BHP for two hours. (D) A representative image of induced wild-type cells (HAM501)
following 0 mM t-BHP for two hours. (E) A representative image of induced wild-type cells
(HAM501) following 5 mM t-BHP for two hours. (F) A representative image of induced cells
lacking ComEA (AAK502) following 0 mM t-BHP for two hours. (G) A representative image of
induced cells lacking ComEA (AAK502) following 5 mM t-BHP for two hours. Lower case
letters were used to denote significant differences between means. “a”, “b”, and “c” are
significantly different mean groups.
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a
b

c

Wild-type

c

Wild-type
Induced

ComEA-

ComEAInduced

Figure 4.7. Cell survival following two-hour exposure to 5 mM t-BHP. Percent cell survival in
the wild-type strain (HAM501) and ComEA-(AAK502) strains either treated with 0 or 1 mM
IPTG following treatment with 5 mM t-BHP. At least nine replicates were completed for each
condition. Lower case letters were used to denote significant differences between means. “a”,
“b”, and “c” are significantly different mean groups.
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CHAPTER 5
CONCLUSIONS AND FUTURE DIRECTIONS

Cells are usually in stressful conditions or in a state of limited replication or stress.
However, most studies of how cells evolve examine actively growing cells. While informative,
studying evolution solely in actively growing cells limits our view of bacterial physiology and
evolution. An increased understanding of bacterial physiology, particularly in conditions of
stress, is essential in addressing current biological problems like how to mitigate disease caused
by bacterial pathogens and the threat of antibiotic resistance.
Stationary-phase mutagenesis, also known as adaptative or stress-induced mutagenesis, is
the process by which non-replicative cells acquired mutations [1, 2]. The work I presented here
aimed to uncover cellular mechanisms that promote the formation of these mutations. Previous
work showed that the transcription-coupled repair factor, Mfd, and transcription promoted
stationary-phase mutagenesis [3-5]. Interestingly, the canonical function of Mfd during DNA
repair involves interactions the nucleotide excision repair pathway proteins (Uvr) [6]. Therefore,
I examined the role of the role of Mfd in combination with the Uvr pathway in stationary-phase
mutagenesis. Using genetic knockouts and a plate reversion assay system, I determined that Mfddependent error-prone nucleotide excision repair was partly responsible for the accumulation of
mutations in stressful conditions. In addition, I demonstrated that the error-prone DNA
polymerase I was crucial for stationary-phase mutations.
Since Mfd-dependent nucleotide excision repair produced only a fraction of mutations in
stressed B. subtilis cells, I studied the involvement of other repair pathways. A genetic knock-out
of MutY, a component of the base excision repair pathway, was examined for its involvement in
stationary-phase mutagenesis [7]. MutY deficiency resulted in the abolishment of the
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accumulation of stationary-phase Arg+ mutants. Morever, the overexpression of MutY in a mfd
mutant did not restore the ability to perform stationary-phase mutagenesis, but the
overexpression of Mfd in a mutY mutant did. We measured Mfd in the latter construct and
showed that Mfd levels were five times higher than in wild-type Mfd+ cells, which suggests that
stationary-phase mutagenesis was increased through upregulated error-prone nucleotide excision
repair.
The interaction of Mfd with MutY in the formation of stationary-phase mutants uncovers
a novel role of Mfd within stressed B. subtilis cells. While our results did not suggest a direct
interaction between Mfd and MutY, we hypothesized that Mfd protected cells from oxidative
damage. This is because MutY acts as a DNA glycolyase on 8 oxo-G:A mispairings which
typically result from oxidative stress [7]. Therefore, because MutY and Mfd worked together to
promote stationary-phase mutagenesis, we wondered if they also worked together to process
oxidative DNA damage. We used genetic knockouts strains and an oxidant survival assay to
determine how Mfd and MutY affected the tolerance of oxidative damage in stressed B. subtilis
cells. Strains lacking either Mfd or MutY had a reduced viability compared to the parent strain;
however, these strains showed similar survival levels when compared to each other. Cells
lacking both Mfd and MutY appeared more sensitized to oxidative stress, yet this was only
statistically significant at the lowest oxidant concentration. This observation suggested that Mfd
and MutY may work additively in tolerance to oxidative stress.
To further investigate the interactions of oxidative stress, MutY, and Mfd on the
accumulation of mutations in stressed B. subtilis cells, we modified our typical stationary-phase
mutagenesis assay to include a two-hour oxidant exposure prior to plating on selective media.
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My experiments showed that Mfd and MutY work in the same pathway to produce mutations in
stationary phase and that this process is potentiated by oxidative damage.
Because reactive oxygen species can damage different cellular molecules, such as
protein, carbohydrates, and nucleic acids, I investigated the influence of Mfd in disulfide stress
tolerance. Disulfide stress occurs when unwanted disulfide bonds occur in proteins and can lead
to protein misfolding, protein aggregation, and cell death [8]. Surprisingly, we found that Mfd
protected cells against the noxious effects of protein oxidation independently of its DNA repairassociated functions. However, how Mfd operates to exert this protective effect is unknown.
Further, cells lacking Mfd did not have altered expression of the yodB gene, encoding a
transcriptional repressor important for cells to respond to disulfide stress.
The involvement of Mfd, error-prone nucleotide excision repair, MutY, and oxidative
damage provide insight into a fundamental challenge of cells undergoing stationary-phase
mutagenesis. This challenge is how cells limit mutagenesis in space to regions of the genome
where a beneficial mutation could allow escape for the encountered stress while avoiding a
deleterious mutation in an essential gene, also known as genetic load [9]. These factors would
bias mutations towards genes that are being actively transcribed under stressful conditions and
away from regions that are repressed. Therefore, this mutagenetic process would be limited to
only genes that are actively transcribed during stress. During transcription, there are times in
which DNA would become single-stranded. Since single-stranded DNA is a more likely
substrate for oxidative damage than double-stranded DNA, this could explain how oxidative
stress potentiates stationary-phase mutagenetic mechanisms [10].
The development of a hyper-mutagenetic subpopulation is another proposed explanation
for how cells may avoid genetic load. In this scenario, a population of stressed cells would limit
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mutagenesis to a subset of cells that enter a hyper-mutagenetic state. This subpopulation strategy
could spare the population from acquiring deleterious mutations. Because stressed B. subtilis
cells undergo cell differentiation, our system easily lends itself to study this possibility. Sung and
Yasbin, 2002, showed that cells lacking ComK, the final transcriptional regulator that controls
the development of competence (also known as the K-state), had reduced levels of Met+
reversions [2]. This supports the notion that a hypermutable subpopulation could be responsible
for stationary-phase mutagenesis.
To further test whether a subpopulation of cells promote stationary-phase mutagenesis,
we modified the our previously published stationary-phase mutagenesis reversion assay to
measure how many of our revertants had undergone development of the K-state. We found that
revertant cells were much more likely to have undergone the K-state than non-revertant
background cells. This observation supported the notion that the K-state promoted stationaryphase mutagenesis. We followed this experiment by constructing a strain deficient in ComEA, a
protein essential for DNA binding and transport into the cell during the K-state and measured the
accumulation of stationary-phase revertants and showed that ComEA- cells displayed similar
levels to ComEA+ cells [11]. This observation validated my hypothesis that recombination or the
transport of nucleotides during competence were not required for stationary-phase mutagenesis.
This suggests that a process other than the transformation of the K-state is responsible for
stationary-phase mutagenesis.
Given that the K-state upregulates factors that detoxify compounds and our previous
results in which oxidative stress potentiates stationary-phase mutagenesis, we examined the
influence of oxidative damage and the presence of a functional competence pore in this process
[12]. K-cells exposed to an oxidant accumulated higher levels of stationary-phase revertants.
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Cells lacking a functional competence pore had reduced levels of stationary-phase revertants and
increased viability following exposure to a high concentration of the oxidant. This result suggests
the competence pore facilitates exposure to oxidative damage which increases mutagenesis and
survival to oxidative stress.
The observations presented here suggest stationary-phase mutagenesis is limited in
genomic space by transcription and to the population that undergoes development the K-state. In
addition, this process is potentiated by oxidative stress. This work is significant as it provides
insights to the process of stationary-phase mutagenesis and unveils novel roles of Mfd in
bacterial physiology. These roles include interacting with MutY to mediate tolerance to oxidative
stress and generate stationary-phase mutation; Also, Mfd protects cells against disulfide stress
independently of its association with DNA repair proteins. Therefore, how Mfd protects against
protein oxidation is an open question. Given the documented interactions of Mfd with RNAP
during the process of transcription, I speculate that Mfd exerts its protective effect against
diamide by altering gene expression of factors that detoxify reactive oxygen species or protect
protein thiol groups. Future research can illuminate which factors are important for the Mfddependent tolerance to disulfide stress.
In addition, our previous observation that Mfd affects the regulation of ohrR further
supports the notion that Mfd modulates mRNA transcript levels. This notion is supported by
several reports on the influence of Mfd in gene regulation in multiple organisms [4, 13-15].
Future studies could elucidate the effect of Mfd on gene regulation and determine if this factor
acts as transcription modulator.
I have demonstrated that oxidative stress potentiates stationary-phase mutagenesis;
however, the mechanistic pathway(s) of how this occurs remains unclear. One hypothesis that
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can explain how oxidative stress mediates the formation of stationary-phase mutants is the
formation of single-stranded DNA and secondary structures which prone single-stranded
residues to lesions caused by reactive oxygen species. The process of transcription places
supercoiling stress on DNA which is relieved by the formation of secondary structures of DNA
that expose single stranded residues to the environment and are more likely to be attacked by
reactive oxygen species than double-stranded residues [10]. These lesions are subsequently
repaired via error-prone repair and can result in stationary-phase mutations. The role of
secondary structures in stationary-phase mutagenesis could be the subject of future experiments.
Moreover, the effect of oxidative damage and the competence pore on the accumulation
of mutations in K-cells is an interesting finding that warrants further investigation. Determining
how the competence pore results in increased oxidative damage would provide insight into
mechanisms of genetic variation during the K-state and bacterial evolution.
In conclusion, the work presented here uncovered mechanisms of stationary-phase
mutagenesis and novel roles of Mfd in bacterial physiology beyond canonical transcriptioncoupled repair. These insights are important in understanding evolutionary mechanisms that
explain the production of mutations that confer antibiotic resistance and increased virulence in
pathogenic bacteria. These observations may help identify potential targets of novel therapies for
bacterial infections.
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